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BACKGROUND
The Drug Situation in Georgia 2014 Report (the Annual Report) is the result of  a collaborative interdisci-
plinary team effort involving experts in the fields of  addictology, epidemiology and psychology. 
The process of  drafting the Annual Report, and its structure, is based on standards of  the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Information is provided on five key 
epidemiological, law enforcement indicators and information available on response to illicit drug markets.
The Annual Report describes the status of  affairs in the area of  drugs in Georgia of  2014. Where possible, 
we show trends of  the indicators.
The reporting period of  2014-2015 has not been marked by any considerable changes in drug situation 
in Georgia: drug use remains criminalized under Georgian legislation, drug users continue to be a hidden 
population, the practice of  street drug testing persists and plea bargain, which falls under prosecutorial 
discretion, remains to be the only mechanism for reducing punishment prescribed by law. 
Since 2014, new psychoactive substances (NPS) have been the focus of  attention in Georgia, which has 
led to the adoption of  special regulations (“Law on New Psychoactive Substances”) and subsequent 
amendments to the Criminal Code of  Georgia to criminalize illegal manufacturing, buying or possession 
of  NPS, and other related actions. The law now includes 9 different classes of  NPS according to their 
chemical structure and the list of  20 substances.  
At the time of  publishing of  this report, the court ruled in a high-profile case that experts believe will 
catalyze subsequent improvements in legislation. The case involved a young musician Beka Tsikarishvili. 
Police found 70 grams of  marijuana on him when he was searched in 2013, and was charged with buying/
possession for personal use of  large amount of  drugs under Article 260 of  the criminal Code of  Georgia. 
He was facing imprisonment from 7 to 14 years. Civil society launched a permanent campaign to support 
him. The case was eventually heard by the Constitutional Court of  Georgia, which ruled in favor of  Beka 
Tsikarishvili in the complaint against the Parliament of  Georgia and found that second paragraph of  the 
Article 260 of  the Criminal Code of  Georgia is unconstitutional (for being in conflict with Article 42 of 
the Constitution).  
During the period of  drafting of  this report, information about use of  psychoactive substances among 
youth or general population in the country was not available. First nation-wide studies were carried out in 
2015-2016 and therefore, will be reflected in subsequent reports about the drug situation. 
Based on research findings, the number of  high-risk drug users in Georgia in 2014 was estimated at 
49,700 (49,208 – 50,192), prevalence among the population between the ages of  18-64 was estimated at 
2,02% (2,00% - 2,04%), and at 1,33% (1,32% - 1,35%) among general population (Curatio International 
Foundation & Bemoni Public Union 2015b). 
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Study of  beneficiaries of  GHRN’s Peer-Driven Intervention (PDI) in ten cities of  Georgia in 2014 
revealed that the most commonly used drug substances among the program beneficiaries over the last ten 
months include: homemade stimulants (30.5%), Desomorphine (31.2%), heroine (30.9%) and Subutex 
(18.1%) (Gogia 2015).
Both preventive activities and social rehabilitation are still fledgling in Georgia and there is no adequately 
developed continuous chain/system of  measures required to manage the problem of  drug abuse, 
comprising of  prevention, treatment/rehabilitation, harm reduction and social rehabilitation. 
Largest share of  treatment costs are paid out-of-pocket by patients, while leading forms of  treatment are 
abstinence-centered, both in-patient and outpatient treatment, and substitution therapy. The number of 
patients engaged in abstinence-centered treatment has reduced over the last 10 years as the number of 
participants of  substitution treatment is growing. Total of  663 patients underwent abstinence-oriented 
treatment in Georgia in 2014, while the opioid substitution therapy had 3,968 beneficiaries. 
While historically injecting drug use was the most common mode of  HIV transmission in Georgia, 
starting from 2010 it has been replaced by heterosexual intercourse. In particular, in 2014 the share of 
injecting drug use as a mode of  HIV transmission was reduced to 34.9% and the share of  heterosexual 
intercourse grew to 52.8%. 
Studies in 7 cities of  Georgia in 2014 revealed that HIV prevalence among injecting drug users varies 
according to cities, with the lowest rate found in Rustavi (0.9%) and the highest in Zugdidi (4.8%) (95% 
confidence interval, 0.2%-11%) (Curatio International Foundation & Bemoni Public Union 2015a). 
There are no credible data on drug related deaths and mortality in the country. According to Levan 
Samkharauli National Forensics Bureau, there were 7 deaths from drug overdose in 2014, while the 
GHRN estimates that there were at least 39 cases of  lethal overdose in Georgia in 2014 (Gogia 2015).
THE DRUG SITUATION IN GEORGIA 7
The team of  authors would like to extend gratitude to professionals, entities and agencies that contributed 
to preparation of  this Annual Report:
This report is made possible through the framework of  projects funded by the European Commission, 
Czech Development Agency and US Agency for International Development (USAID):1
Colleagues from Prague Charles University, Department of  Addictology, First Faculty of  Medicine and 
Czech National Monitoring Centre on Drugs and Addictions for methodological, technical, institutional 
and collegial support;
Local partners and international organizations in the field: Georgian Harm Reduction Network, Georgian 
Association of  Addictologists, Curatio International Foundation, Centre for Mental Health and Prevention 
of  Addiction, private clinics Bemoni, Uranti and Neogeni, non-governmental organizations Tanadgoma, 
Akhali Gza, Akhali Vektori, Hepa Plus, Peoni and Kamara; Open Society Georgia Foundation, and UN 
agency – International Organization on Migration. 
And these national agencies: Ministry of  Justice and Inter-agency Council on Combatting Drug Addiction, 
Ministry of  Labor Health and Social Affairs, the National Centre for Disease Control and Public Health, 
Ministry of  Internal Affairs, Ministry of  Education and Science, and the Supreme Court of  Georgia. 
1 This report is published with international support, and contributions from two major programs:– Development of  Human 
Resources , Evidence-based Approaches and Quality Standards In Addictology in Georgia (funded by TEMPUS, ADDIGE; and 
European Union), and  Addiction Research Development in Georgia  (funded by USAID and Czech Development Agency).
GRATITUDE
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1.1.  INTRODUCTION
Georgia’s Drug Policy has traditionally, focused its efforts on supply reduction rather than demand 
reduction and prevention. Therefore, in response to drug abuse, restrictive and punitive measures outweigh 
public health, social protection and inclusion approaches. 
In recent years, a series of  steps have been taken to develop institutional mechanisms for implementing 
a coordinated Drug Policy. In 2011, the Inter-agency Coordination Council for Combatting Drug Addiction (the 
Council) was created under the leadership of  the Ministry of  Justice. In 2012-2013 the Council facilitated 
development of  the National Strategy for Combatting Drug Addiction, which was further developed into an 
Action Plan. The National Strategy for Combatting Drug Addiction planned to establish the National Centre for 
Drug Monitoring in Georgia in 2014; however the Drug Monitoring Centre had not yet been established as 
of  the publication of  this report  in mid-2016.
1.2. LEGISLATIVE FRAMEWORK
1.2.1. Drug-related Laws and Normative Acts 
Pursuant to administrative and criminal laws, the use of  drugs in Georgia is criminalized. Article 45 of  the 
Administrative Offences Code states that the first case of  using drugs without prescription, or the possession 
in of  drugs in small amounts (e.g. for personal use) without intention of  sale, carry a fine of  500 GEL (220 
€)2 or in exceptional cases, administrative imprisonment for up to 15 days. If  an individual is caught using 
drugs more than once during the same 12 months, they will be punished under the Criminal Law (Article 
273 of  the Criminal Code of  Georgia) and subject to a range of  fines and up to 12 months of  imprisonment. 
Article 116 of  the Administrative Offences Code of  Georgia contains provisions for driving a vehicle under the 
influence of  drugs and/or psychotropic substances, as well as for refusal to undergo toxicological testing 
on drugs, which leads to driving license suspension for a term of  three years (untill 2014 there was also 
Article 117, however this disposition has been moved to Article 116). 
Testing individuals for drug intoxication/consumption is regulated by joint Order No. 1244-278/n of 
the Ministry of  Internal Affairs, and the Ministry of  Labor, Health and Social Affairs. The order was 
issued based on Article 45 of  Administrative Offences Code of  Georgia in 2006. Before 2013, as per the 
Order, police were authorized to stop citizens in public and require them to submit to an examination 
and urine screen test for suspected drug intoxication or consumption. Reasonable suspicion is the 
criteria for requiring an individual to submit to examination and testing for the presence of  psychoactive 
2 Official exchange rate at the end of  2014, 1 Euro=2.27 GEL (National Bank of  Georgia) 
1. DRUG POLICY: LEGISLATION, STRATEGIES AND 
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substances in their system. However, the term “reasonable suspicion” was not defined, and, therefore, it 
enabled subjective individual interpretation. In 2013, the Law on Police replaced this term of  “reasonable 
suspicion” with a wording “sufficient grounds for assuming (presuming)”. Despite these changes, the 
procedure remains highly subjective with the same level of  uncertainty.
Identification of  drug use by an individual stopped in public is determined using rapid test and/or clinical 
urine screening test. This protocol does not provide for individuals with properly substantiated results and 
does not necessarily include confirmation of  rapid test results. 
Illegal sale of  drugs and/or psychotropic substances, illegal manufacturing, storage, production, 
distribution, import or export is punishable under the Criminal Code of  Georgia (for details see Annex 
1: Chapter XXXIII of  the Penal Code of  Georgia: Drug-related offences). In 2015, an amendment was 
made to the Article 260 of  the Criminal Code of  Georgia; which reduced punishment for manufacturing, 
production, purchase and transportation without intent to sell, from up 12 years to up to 6 years. 
Severity of  punishment for drug-related crime depends on aggravating factors such as the amount 
of  drugs seized. Controlled amounts are regulated by the revised Law of  May 22, 2012 on Drugs, 
Psychotropic Substances, Precursors and Narcological Aids (so-called Framework Law); Annex No. 2 
establishes small, large, or extremely large amounts for more than 200 controlled substances and 67 
psychotropic substances. For many of  the most commonly used psychoactive substances in Georgia such 
as amphetamine, methamphetamine and desomorphine (see Chapter 2) “small amounts” have not yet 
been determined. Therefore, any amount of  these substances – even trace amounts left in the syringe - 
substances may be considered large and therefore punishment may be more severe. 
In order to combat illegal supply of  new psychoactive substances and avoid potential harm to public 
health, the Law on New Psychoactive Substances was adopted on April 16, 2014. The Law defines nine 
classes of  chemical compositions (compounds) of  new psychoactive substances and 20 new psychoactive 
substances. Relevant provisions of  the Law were added to the Criminal Code of  Georgia which established 
provisions making it illegal to manufacture, purchase, or store these 9 new chemical compounds and 20 
new psychoactive substances.  
In response to the use of  homemade psychoactive drugs, primarily those including opioid based drugs 
like desomorphine (“crocodile”) made of  codeine, the Law on Drugs, Psychotropic Substances, Precursors and 
Narcological Aid was amended in 2014 based on joint initiative of  the Ministry of  Internal Affairs, and the 
Ministry of  Labor Health and Social Affairs; which establishes criminal liability for sale of  substances 
containing codeine, ephedrine, norephedrine and pseudoephedrine. 
Pursuant to the Law on Combatting Drug Crime3, “a person, user of  drugs”4 is deprived of  personal freedoms 
(e.g. drive a vehicle) and the deprived of  the right to occupy a position or certain jobs (medical job, 
lawyer, pharmacist, public and local self-governance related jobs). These rights shall be seized based on a 
court decision for a term of  3 years or more. The Law has been amended several times and in 2014 key 
amendments were added which included deprivation of  the right to maintain  pharmaceutical activities, 
or reinstatement of  these rights after one third of  the timeframe for these penalties  has been completed. 
Early reinstatement may be achieved through plea bargain provided the subject has exhibited “good or 
appropriate behavior.”
3  Law came into force in 2007
4  A person who committed a crime under the article 273 of  the Criminal Code of  Georgia
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1.2.2. Application of  the Law
The Judiciary applies the Law in accordance with the legal framework and recommendations of  the Supreme 
Court of  Georgia. (for details see Annual Report on Drugs Situation in Georgia for 2013, Javakhishvili, 
Otiashvili, and Tabatadze 2013).
A plea bargain provides an opportunity and means for mitigating the punishment under the Law. Plea 
bargains are conducted at the Prosecutor’s level. A substantial portion of  people arrested for narcotics 
use, purchase and storage, avoid imprisonment through plea-bargaining. Significant amounts of  money 
received through plea bargain agreements are channeled into the law enforcement and criminal justice 
budget (see Chapter 9).
When a plea bargain agreement cannot be reached (e.g. fails due to restricting legal strategies in force) 
and the confiscated amount of  drugs qualifies as a “large amount of  narcotics” (purchased and stored 
for personal use), then the drug related sentence could be lengthy (7-14 years). In recent years the severity 
of  punishment for cannabis (marijuana) began to change in response to the case of  Beka Tsikarishvili a 
well-known musician and public figure. In summer 2013 Mr Tsikarishvili was  in possession of  70 grams 
of  cannabis (marijuana) which constituted a “large amount” under Article 260/2 of  the Criminal Code 
which carried a 7-14 year prison sentence. Investigation of  his case continued throughout 2014, the 
case moved to the Constitutional Court and was concluded in October 2015.  Beka Tsikarishvili and his 
numerous supporters believed that the punishment was not proportionate, far too severe and would incur 
dignitary harm. The public campaign “Beka is not a criminal” greatly affected the process of  the case and 
its outcome. The claim concerned the anti-constitutional nature (conflicting with the Article 42 of  the 
Constitution of  Georgia) of  Article 260/2.a of  the Criminal Code of  Georgia. Ultimately, Beka’s party 
won the case. According to experts, this loud case will not only leave its trail in terms of  Law application, 
but it will also trigger legislative amendments. 
1.2.3. National Action Plan and Strategy, their Evaluation
The Inter-agency Coordination Council for Combatting Drug Addiction approved the National Strategy for Combatting 
Drug Addiction and the accompanying Action Plan on December 4, 2013. Both documents were developed with 
active participation of  stakeholders including experts, and both international and local non-governmental 
organizations (NGO’s). Key thematic directions of  the Strategy include; supply reduction, demand 
reduction, harm reduction, overcoming stigma and discrimination, coordination and international 
cooperation, in addition to research and data analysis. 
Despite the fact that the 2014 Action Plan is detailed, and specifies responsible agencies/persons, 
participating institutions, necessary expenditures, timeframes, and measurable assessment indicators, no 
research  evaluating process or outcomes of  implementation was conducted by the State or the non-
governmental sector; therefore, it is not possible to asses dynamics of  implementation or draw any 
conclusions. 
1.2.4. Coordination Mechanisms
The key coordination mechanism for addressing illicit drug trade in Georgia is the Inter-Agency Coordination 
Council for Combatting Drug Addiction (IACCDA or the Council), established in 2011 through Presidential 
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Decree and embedded in the Ministry of  Justice. The aims of  the Council are to: a.) Develop policies 
for prevention of  drug addiction that are grounded in human rights; and b.) Develop the State Anti-
drug Strategy with corresponding action plans, (including inter-agency coordination, implementation, 
monitoring, and periodic revisions as needed). In addition to government agencies, the Council invites 
select international organizations, NGOs and experts (without a right to vote) to participate in the work 
of  the Council. The Council was mandated to establish the National Drug Monitoring Centre/National 
Focal Point (NFP) on Drug Information and began work on the NFP in 2014, however as of  mid-2016 
the NFP had not been established.  
The Commission for Facilitating Prevention of  New Psychoactive Substances (CFPNPS – the Commission) is 
another national inter-agency body, which was created in response to the emerging use of  new synthetic 
psychoactive substances and established by joint Order5 of  three ministries and Article 6 of  the Law on 
New Psychoactive Substances. The commission comprises representatives of  the Ministry of  Internal 
Affairs (MIA), Ministry of  Labor, Health and Social Affairs (MoLHSA), and the Ministry of  Finance of 
Georgia (MoF). Similar to the practices of  the Inter-Agency Council, the Commission solicits input from 
experts on an as-needed basis. 
1.2.5. Other Developments in Drug Policy
Beginning in 2013 a working group was created to examine pharmaceutical markets based on the memo-
randum signed between the Ministry of  Internal Affairs of  Georgia  and  the Ministry of  Labor, Health 
and Social Affairs.
As a result of  the advocacy efforts of  the professional community activists working on drug policy, 
and civil society organizations, the MoLHSA issued an order in August 2014 under which health care 
providers are no longer obliged to inform the police about cases of  drug related overdose6. It is expected 
that this change will increase access to medical services needed in cases of  overdose, and therefore reduce 
overdose deaths.  
1.3.  ECONOMIC ANALYSIS
Traditionally, there has been no system tracking drug related expenditures in the country.  This is due to 
the fact that the funding amounts allocated for and/or spent for drug related policy enforcement are not 
publically identifiable in institutional budgets or cost accounting reports. However, tracking drug related 
costs incurred by international non-governmental organizations (NGO’s) and the Ministry of  Labor, 
Health and Social Affairs is possible because their budgets and costs are broken down by content areas, 
including drug-related health and policy expenditures. Based on the information available the Addiction 
Research Center Alternative Georgia conducted a study revealing certain trends of  drug expenditures in 
the country.
There are three main funding sources in the healthcare sector: 1.) Public funding for state budgets (primary 
funding sources are taxation and fines), 2.) International NGO’s (primary funding source is the Global 
5  Order # 344/#01-30/n/#147 from  May 13 2014 of  the Minister of  Internal Affairs, Minister of   Labor, Health and Social 
Affairs and Minister of  Finance of  Georgia (Commission was created based on the Law on New Psychoactive Substances and 
paragraph 1.1 of  the given Order) 
6 Before 2014 such an obligation was defined by the Order # 239/n from 5.12.2000 of  the Minister of  Labor, Health and Social 
Affairs 
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Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund)), and 3.) Private sources (patient payment). 
In 2014 expenditures from all sources increased substantially from previous years. The amounts paid by 
the 2014 State Budget and out-of-pocket patient payments doubled from 2013 to 2014. Allocations and 
expenditures from international donors during this time period increased threefold. Significant increases 
in Global Fund spending on Programs targeting injecting drug users (IDU’s) in 2014 may be attributed 
to the shift in the Global Fund priorities and focus on key target groups and effective and cost-effective 
interventions. (See Table 1 for detailed information.)
As for private expenditure increases (patient payments), it is possible that in previous years such expenses 
were not accurately recorded or reflected in reports. It is, otherwise, difficult to explain why total patients’ 
out-of-pocket payments doubled while the scale of  treatment did not double and the payment per patient 
per month remained unchanged at 110 GEL (48.50 €).
Table 1: Drug Related Health Expenditures for 2012-2014, thousand GEL 
(Ministry of  Labor 2015)
 Public International Private
2012 2013 2014 2012 2013 2014 2012 2013 2014
Harm reduction including 
agonist substitution therapy 1,317
1 1,2721 3,773.51 1,416 1,228 5,272.5 6142 1,2682 3,572.92
Voluntary counseling and 
testing (VCT)3 125 105 580.5 676 453 489.2 0 0 0
Free in- and out-patient 
treatment and primary post-
detox rehabilitation
u/k 628 615 0 0 0 u/k4 u/k4 u/k4
Total 1,442 2,005 4,388.5 2,092 1,681 5,761.7 614 1,268 3,572.9
1covers substitution therapy; public funding does not cover needle and syringe exchange 
programs                                                                                                                                                                                                 
2amounts paid by patients towards agonist substitution therapy
3 covers funding of  voluntary counseling and testing of  sex workers and men having sex with men (MSM)  
4 unable to obtain record of  patients’ contribution to hospital or outpatient treatment. Private treatment provider pays these 
expenses and no record could be obtained. 
u/k indicates unknown or unavailable information
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2.1.  INTRODUCTION
The first general population survey on drug use (the Survey) was conducted in December 2015, the year 
following the period covered in this report, through the USAID-funded Addiction Research Development in 
Georgia project. The Survey was conducted by the Addiction Research Centre “Alternative Georgia” in 
partnership with the National Centre for Disease Control (NCDC); Addictology Department of  the Charles 
University in Prague provided methodological support. Research results will become available in 2016. 
Similarly, the first national survey of  drug use among young people based on ESPAD (European School 
Project on Alcohol and Drugs) methodology, on use of  psychoactive substances (alcohol, tobacco and 
illicit drugs) was conducted in the fall of  2015 by the National  Centre for Disease Control (NCDC) with 
methodological and financial support from EMCDDA - European Monitoring Centre for Drugs and Drug 
Addiction. Results of  the Survey will become available in 2016. 
2.2.  DRUG USE IN A GENERAL POPULATION
National drug use data is currently unavailable; data will be made available in late 2016.
2.3.  DRUG USE AMONG YOUTH 
The most recent available data on use of  psychoactive substances among school age youth and emerging 
adults was conducted by various organizations in several towns across Georgia in 2012.  Results of  these 
studies can be found in the Drug Situation in Georgia Report for 2013 (Javakhishvili, Otiashvili, and 
Tabatadze 2013).
2.4. DRUG USE IN DIFFERENT TARGET GROUPS AT NATIONAL 
AND LOCAL LEVELS
Epidemiological surveys among high-risk groups/populations for HIV/AIDS and other blood-borne 
diseases have been conducted in Georgia since 20027. 
7 Save the Children Federation’s office in Georgia, with financial support from the United States Agency for International Development (US-
AID), and the Bio-Behavioral Surveillance Survey (BBSS). The first round of  the BBSS was conducted in 2002 in Tbilisi among 
commercial sex workers, the second and third rounds were conducted in 2004 and 2006 covering Tbilisi and Batumi. The next 
rounds of  BBSS, with the financial support from Global Fund continued in both cities, in 2009, 2012 and 2014. For more infor-
mation see the corresponding annual  Drug Situation in Georgia reports.
2. DRUG USE IN THE GENERAL POPULATION 
AND SPECIFIC TARGET GROUPS
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2.4.1. Drug use among commercial sex workers 
In 2014 the sixth round of  the Bio-Behavioral Surveillance Survey (BBSS) among commercial sex workers 
was conducted by the Curatio International Foundation together with Centre for Information and Counseling 
Tanadgoma. The BBSS research has been conducted in the two largest cities in Georgia - Batumi and 
Tbilisi. The aims of  this ongoing research are to measure the prevalence of  HIV infection, Hepatitis 
C (HCV), gonorrhea and syphilis and related health risk behaviors. The 2014 study employed stratified 
time and location sampling methodologies. A total of  280 female sex workers were surveyed (n=160 in 
Tbilisi and n=120 in Batumi). The median age of  respondents in Tbilisi was 40 and 38 in Batumi; with 
almost half  of  respondents over the age of  40 (50.6% in Tbilisi and 42.5% in Batumi). The majority 
of  respondents were Georgian nationals (83.8% in Tbilisi and 92.5% in Batumi), with secondary and 
vocational education (79.4% in Tbilisi and 82.5% in Batumi). The home residences of  the majority of  sex 
workers are different from the locations of  their sex work. In Tbilisi 71.9% of  respondents and 93.3% 
of  respondents in Batumi stated that they are from other towns and cities of  Georgia. More than 60% 
of  respondents are divorced or separated. Majority of  respondents (70% in Tbilisi and 67.5% in Batumi) 
noted that they had participated at least in one of  the previous BBS surveys. 
In reference to their use of  psychoactive substances, the 2014 BBSS revealed the following (See Table3): 
The prevalence of  daily alcohol consumption varied widely by location; 21.7% (n=26) drank daily in 
Batumi while only 9.4% (n=15) of  respondents in Tbilisi reported consuming alcohol on a daily basis 
during the previous 12 month period. Injecting drug use was low with 1.9% (n=3) in Tbilisi and 0.8% in 
Batumi (n=1) reporting injecting drug use in the last 12 months. The injecting drug users were relatively 
young and reported injecting Subutex and heroin. In Tbilisi 6.3% of  respondents reported other non-
injecting drug use with a similar rate of  5.8% in Batumi. The most prevalent non-injecting drugs used by 
respondents were prescription sedative/tranquilizers.
Table 2: Use of  alcohol and illegal drugs by female sex workers in the last 12 months in 2014 
(Curatio International Foundation & Medical-Psychological Center Tanadgoma 2015)
Alcohol and Drug Consumption % n/N
Daily alcohol use 14.6 41/280
Non-injecting drug use 6.1 17/280
Sedatives/sleeping pills 4.3 12/280
Injecting drug use 1.4 4/280
Subutex® use 1.4 4/280
Heroin use 0.7 2/280
2.4.2. Drug use among men having sex with men (MSM)
Curatio International Foundation and Centre for Information and Counseling Tanadgoma jointly conducted a cross-
sectional study in 2012 among men having sex with men (MSM). The aim of  the Research was to assess 
HIV-infection risk behavior among the MSM population. In Tbilisi, 218 MSM were interviewed. Median 
age of  men was 27, more than half  of  them (55%, n=120 respondents) had completed higher education, 
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the vast majority – 90% (196/218) – were ethnic Georgians; 72% (156/218) have never been married. 
In regards to substance use, 9.2% (20/218) reported using alcohol daily in the previous 12 months, and 
17.9% (39/218) reported using illicit drugs at least once in the previous 12 months. Cannabis was the 
most prevalent illicit drug used. A small percentage (6 respondents) reported injecting drug use in the 
previous 12 months; four used buprenorphine; only 1 reported sharing a syringe. See Table 3 for results.
Table 3: Past year prevalence of  alcohol and illicit drug use among MSM 
(Curatio International Foundation and Centre for Information and Counseling Tanadgoma, 2012)
Last year prevalence %  (N=218)
Daily consumption of  alcohol 9.2
Non-injecting drug use 17.9
Injecting drug use 2.8
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3.1.  INTRODUCTION
As of  the writing of  this report, preventive science is not recognized and not practiced at the government 
level in Georgia. Therefore, prevention “activities” across the country are rarely based on scientific 
evidence and are not assessed in terms of  effectiveness, ethics, or quality pursuant to UN standards 
(UNODC, 2015). In order for substance abuse prevention to be effective it must be based in science, 
implemented with fidelity, and be made available to the population across the lifespan (The National 
Centre on Addiction and Substance Abuse, 2015;  Inaba & Cohen, 2014; Saxena, Llopis, & Hosman, 2006; 
UNODC, 2015).
Over the past decade Georgia’s national education curriculum has begun to incorporate information 
on healthy lifestyles under the auspices of  primary prevention. Since 2013 provision of  information 
on HIV/AIDS related risk behaviors (including substance use) is supposed to be integrated into the 
science curriculum and delivered during biology classes for students ages 15-18. However, there is no 
consistent systematic approach for prevention education within the school curricula. Moreover, there are 
no evidence-based prevention programs that provide children (younger than 15) with information and 
understanding of  the risks of  substance use or misuse. Provision of  evidence based prevention prior 
to early adolescence, when oppositional behavior and experimentation begin, is necessary for effective 
prevention (The National Centre on Addiction and Substance Abuse, 2015; Levi, Segal, Blasi, & Martin, 
2015; Wittchen et al., 2008). Preventive interventions for youth before early adolescence are primarily 
extracurricular, fragmented and activity based (e.g. campaigns, contests, conferences) rather than outcomes 
based programs and strategies. Research has found such programs to be ineffective and unsustainable while 
leaving children ill-informed about risks factors and void of  opportunities for developing population level 
protective factors (The National Centre on Addiction and Substance Abuse, 2015; National Institute of 
Drug Abuse, 2003; O’Connell, Boat, & Warner, 2009).
3.2.  PREVENTION SYSTEM, STRATEGY, POLICY
According to data from the Ministry of  Education and Science (MoES), in 2014 anti-drug and anti-
nicotine topics were presented in natural sciences (grades 8-9) and civic education (grades 9-10) classes in 
public and private schools; in addition, some thematic contests, conferences and prevention campaigns 
were conducted. No evaluative data has been collected on knowledge and attitudes of  children towards 
psychoactive substances before and after these strategies were implemented. 
In 2014 the MoES developed a general education policy paper, titled the “School Environment Policy.” 
The policy included a healthy lifestyles curriculum that was piloted in 10 public schools. The Ministry 
planned to disseminate the policy and program in all public schools in Georgia in 2015. 
3. PREVENTION
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3.3. ENVIRONMENTAL STRATEGIES
The Code of  Administrative Offences of  Georgia regulates use and distribution of  tobacco and alcohol. 
Tobacco policies prohibit the following: a.) smoking tobacco in public places (including public 
transportation), educational and medical institutions, and in buildings/institutions serving children 
under 18; b.) selling tobacco products to persons under 18 and/or involving them in the tobacco sales 
or distribution business, c.) the sale of  tobacco in pre-school facilities, near schools or near children’s 
sections of  shopping centers; and d.) it is prohibited to advertise smoking or broadcast images of  smoking 
through television and mass media. However, marketing of  tobacco on large billboards in visible locations 
is permissible. The Code of  Administrative Offences regulates such advertisements and requires the 
inclusion of  health warning signs on tobacco products/packages and advertising billboards.
Alcohol consumption is prohibited in public places, and it may not be sold to persons under the age of 
18. Article 116 of  the Code of  Administrative Offences prohibits driving a motorized vehicle while under 
the influence of  alcohol or other psychoactive substances. 
Individuals who work for state institutions and public services may be required to undergo a medical exam 
and alcohol or other drug testing. A medical certificate of  the employees’ health conditions and alcohol 
and other test results are then submitted as a condition of  employment per Georgian Law of  Georgia on 
Civil Service (Parliament of  Georgia 1997).
Under the Ministry of  Education and Science framework of  the Safe School Program, the Legal Entity of 
Public Law (LEPL) the Bailiffs’ Service “Mandatory” functions have been to “maintain public order and 
safety in educational facilities. In order to eliminate violence and establish healthy lifestyle in educational 
facilities, the Bailiff ’s Service ensures that students do not carry any cold weapons or firearms, or consume 
alcohol and any other psychoactive substances ( MoES,  2014). The Bailiffs’ Service has carried out these 
functions in all public and some private schools since 2010. Bailiffs have been required to undergo special 
training and pass minimum training standards that include identification of  signs and symptoms of  drugs 
use.
3.4.  UNIVERSAL PREVENTION
According to information provided by the MoES, in the framework of  the 2013-2015 action plan of  the 
State Anti-drugs Strategy, the following universal prevention measures were performed during 2014:
A National Curriculum Plan, which included content on how to combat so called “vicious habits”, was 
integrated into the natural and social sciences and sports curricula. The relevant content is published on 
the web-portal http://elibrary.emis.ge/ge; http://ncp.ge/ge/home and is publicly available. And a special 
guidebook titled “Healthy Lifestyle” is in development to support this curriculum and will be published 
on the national curriculum web-portal and e-library of  the MoES.
All schools received copies of  the textbook on “Legal Culture” where one chapter is dedicated to “vicious 
habits and corresponding dangerous results” (MoES, 2015).
The Headmasters’ program was complemented by priority topics on healthy lifestyle, such as “individual 
health as value”, “healthy lifestyle, sports”, “damage from vicious habits”, “assessing correct and incorrect 
behaviors”, “developing refusal skill and how to say no”, etc.. 
ANNUAL REPORT, 201418
In 2014 LEPL National Centre for Professional Development of  Teachers introduced a special program for 
school teachers in class supervision; within the frame of  this program, knowledge and skills necessary 
for introducing healthy lifestyle through classroom based curricula were developed among program 
participants. In 2014, 350 teachers participated in this program.
According to the MoES, one of  the priorities for prevention interventions in 2013-2015 has been 
institutionalization of  various initiatives on healthy lifestyle suggested by educational facilities, non-
governmental and private organizations. With technical assistance of  the Georgian HIV Prevention Project 
(GHPP), MoES first introduced the healthy lifestyle curriculum during the 2013-2014 academic years, 
with the use of  a specialized textbook for biology teachers. Students 15-18 years old receive information 
on HIV/AIDS, illicit drugs, tobacco, and alcohol use related harm and early pregnancy risks through 
their biology courses. According to prevention science, it is critical to integrate prevention work in the 
school curriculum  not only at the stage of  adolescence, but also across the lifespan thus providing a 
continuous chain to support developing healthy lifestyle related skills prior to adolescence, when they 
manifest oppositional attitudes and behavior (The National Centre on Addiction and Substance Abuse, 
2015; UNODC, 2015).
3.5.  SELECTIVE AND INDICATED PREVENTION
Since 2013 the Child Care and Psychological Assistance Centre (CCPAC – the Centre) has been operating in 
Tbilisi under the LEPL Bailiffs’ Service of  the MoES; as an institutional mechanism of  indicated prevention. 
The primary clients of  the Centre are children and adolescents with behavioral problems referred by 
schoolteachers, administrators and bailiffs. As of  2014, branches of  the CCPAC were opened in Batumi, 
Kutaisi, Poti, Telavi, and Gori Bailiffs’ regional offices. 
In 2013, with assistance of  the Ministry of  Corrections of  Georgia, the Psychological Education Prevention 
Program was introduced for convicted juvenile offenders, probationers and other at-risk groups of 
adolescents. The aim of  the program are to promote and normalize healthy lifestyles and prevent misuse 
of  psychoactive substances.
3.6.  PREVENTION CAMPAIGNS
Anti-drug campaigns in Georgia are the most common forms of  universal prevention measures; however 
they are not evidence-based and have not been scientifically evaluated. Outcomes based research is needed 
to determine the effectiveness of  these interventions. 
Annually, including 2014, the LEPL National Centre for Disease Control under the Ministry of  Labour, Health 
and Social Affairs conducted anti-tobacco awareness campaigns which consisted to the publication and 
dissemination of  various leaflets and brochures on the harms of  smoking tobacco. 
According to information from the Ministry of  Education and Science, the “School Essays and Drawings” 
program for “Provision of  Incentives for Specifically Talented Young People” approved by Order No. 
233 on 6 March 2014, the drawings and essays competition on anti-drugs topic was held. Youth authors 
of  selected essays addressed peers with one-minute speeches. 
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In 2014, the Ministry of  Internal Affairs (MIA) conducted a large-scale anti-drug campaign to prevent the 
use of  Bio-drugs (new synthetic compounds); the title of  the campaign was “No to Bio-Drugs – Let us 
change attitudes together!” The aim of  this campaign was to disseminate information on adverse results 
of  drug use and the illegal sale and circulation of  these drugs. The specific focus of  the campaign was 
the new psychoactive substances called “Bios” in Georgia. According to the MIA, the following events 
were conducted under the framework of  this campaign: anti-drug public service announcements (PSA’s) 
were developed; MIA representatives met with school and university students to discuss “Bios”; a special 
competition for the best anti-drug media-products was held with participation of  students from the 
Tbilisi State University Journalism School. According to the MIA, “key messages of  the campaign reached 
all segments of  population, especially the most vulnerable group of  youth, which, naturally, facilitated 
reduction of  drugs use and prevention of  drugs use in the country” (MIA, 2015b).  
In March 2014, the government of  Georgia approved a new version of  the State Youth Policy that had 
been developed in 2013 under the coordination of  the Ministry of  Sport and Youth Affairs of  Georgia 
with input from several agencies. The State Youth Policy underscores the importance of  providing 
healthy lifestyle information to Georgian youth. According to the Ministry of  Sport and Youth Affairs, a 
priority of  the State Youth Policy in 2014 was “healthy lifestyle and engagement of  youth in cultural and 
creative activities” with the aim of  increasing awareness of  health and popularizing healthy lifestyles. A 
variety of  cultural, creative and sports events were held as part of  the programs which included students’ 
days, educational events, intellectual competitions, and sports events with the slogan “Choose a Healthy 
Lifestyle.” In 2014 the Ministry of  Sport and Youth Affairs also conducted an anti-tobacco awareness 
campaign, which included the publication and dissemination of  informational anti-tobacco materials 
during the aforementioned events (Ministry of  Sport and Youth Affairs of  Georgia, 2015). 
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4.1.  INTRODUCTION
Term “high risk drug use” is used as an analogue for what was previously referred to as “problem drug 
use” and both terms in Georgia imply “injecting” drug use. This is a narrower definition than the term 
used by the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) 8. Information 
on high-risk drug use in Georgia is based on the following sources: Bio-behavioral Surveillance Surveys 
(BBSS), population size estimation studies, and program data from service-providing organizations. Since 
2002 surveys have been performed biannually by the non-governmental organizations Bemoni Public Union 
and Curatio International Foundation with support of  international organizations.
4.2.  PREVALENCE OF INJECTING DRUG USE
Bio-behavioral Surveillance Surveys (BBSS) are conducted every two years in Georgia. In 2014, it was 
conducted in seven cities by the Curatio International Foundation and Bemoni Public Union with support of  the 
Global Fund to Fight AIDS, Malaria and Tuberculosis (GFAMT). The BBSS was a questionnaire that utilized 
respondent-driven sampling methods and recruited 1,951 participants. For purposes of  identifying 
prevalence of  problem drug use, a multiplier method was used, as well as a modified version of  capture-
recapture methodology and network size estimation methods. Final estimates were established by 
triangulation of  data generated through these methods. An experts’ consensus meeting was conducted to 
review research results; the group determined that in 2014 the estimated number of  high risk drug users 
was 49,700 (49,208-50,192), prevalence of  high risk use among the 18-64 age category was 2.02% (2.0%-
2.04%), and 1.33% (1.32%-1.35%) among the general population (Curatio International Foundation & 
Bemoni Public Union, 2015b).
For comparison, we present the results of  the same study previously conducted in 2012 by Curatio 
International Foundation and Bemoni Public Union. In 2012 the estimated number and prevalence of  injecting 
drug users was calculated based on four different methodoligcal approaches for multivariate indicators 
and coefficients; in addition, nomination techniques were used in the survey of  a hidden population (6 
cities of  Georgia, N=1,791) using respondent-driven sampling. Following the completion of  the 2012 
study an expert consensus meeting had also been conducted. Consensus was reached to set the estimated 
number of  high risk drug users in Georgia at  45,457, and the prevalence in 18-64 age group was set at 
1.65% (Curatio International Foundation & Bemoni Public Union, 2012). Because the same methodology 
was used in both the 2012 and 2014 studies, it can be concluded that the prevalence of  high risk users has 
increased since 2012 (Curatio International Foundation & Bemoni Public Union 2012)9.
8 The European Monitoring Centre for Drugs and Drug Addiction, http://www.emcdda.europa.eu/activities/hrdu 
9 In 2009 in 5 towns of  Georgia – Tbilisi, Batumi, Telavi, Gori and Zugdidi – the research on injecting drug users was conducted; 
according to it (N=1 127) following parameters are received: 39 000-41 000 high risk drug users, and prevalence in the 18-64 age 
group is 1.5% (1.48% - 1.52%) (Curatio International Foundation & Bemoni Public Union 2010); but due to methodological 
differences it is impossible to compare data of  2012 and 2014: in 2009 the coefficient was used based on information received 
from various sources on injecting drug use and a research implied respondent oriented sampling. 
4. HIGH RISK DRUG USE
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4.3. CHARACTERISTICS OF HIGH RISK DRUG USERS
4.3.1. Data from Georgian Harm Reduction Network 
Georgian Harm Reduction Network (GHRN) annually collects routine data on beneficiaries of  the HIV/AIDS 
prevention program. In 2014, GHRN conducted a survey among participants of  the peer-driven intervention 
(PDI) to study prevalence of  psychoactive substances or injecting drug use and related risk behavior. 
Notably, this survey aimed to recruit hidden populations that have never been in contact with HIV/
AIDS prevention services. A total of  1,728 injecting drug users were interviewed (6% female) from 10 
cities of  Georgia (Tbilisi, Gori, Telavi, Zugdidi, Batumi, Kutaisi, Samtredia, Poti, Ozurgeti, Rustavi). The 
median age of  respondents was 34 (mean=34.8, SD=10.8, range 18-75 years); average length (duration) of 
injecting drug use was 10 years (mean=10.9, SD=8.1, range 1-40 years). At the time of  the survey, 73.4% 
of  respondents were unemployed, 41.5% had never been married, and 39.6% had incomplete secondary 
or higher education.  
Figure 1: Prevalence of  psychoactive substances use in the last 30 days
(Gogia 2014,Gogia 2015)
As Figure 1 shows the past month use rates among PDI participants for homemade stimulants, 
desomorphine and heroin were similar (~31%) to one another in 2014. Compared to 2013, the prevalence 
of  use had decreased across all substances with the exception of  buprenorphine. The most notable 
shifts from 2013 to 2014 occurred between alcohol (20.9% point decrease), desomorphine (13.3% point 
decrease) and buprenorphine, which increased 7.2% points. Data presented is statistically significant  p < 
0.001).
Among women (n=103), the use of  homemade stimulants (48%) was more common than all other illicit 
psychoactive substances, and nearly equal to rates of  alcohol use (50%) (See Figure 2).
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Figure 2: Use of  psychoactive substances and drugs by women in the last 30 days, 2014
(Gogia 2015)
Analysis of  past-month use of  psychoactive substances by age group, found that use was highest among 
the 31-40 year old age group for all substances except homemade stimulants, which were most heavily 
used by 18-24 year olds (see Figure 3).
Figure 3: Prevalence of  psychoactive substances used in the last 30 days by age groups
(Gogia 2015)
Sharing of  needles and/or paraphernalia during the last injecting was reported by 5.5% of  respondents, 
6.8% reported sharing syringes in the past month and 17.6% reported having shared a syringe during 
the previous 6 months. Forty-six percent of  those who reported having shared a syringe stated that 
they shared a syringe with one person, while the others shared it with two to three people. Despite such 
high-risk behavior, the level of  HIV testing was relatively low. The majority of  women (65.7%) and men 
(86.4%) surveyed had never been tested for HIV. 
Only 7.4% (n=128) of  respondents had undergone opioid substitution therapy (OST) using methadone. 
Fifty-one percent of  respondents (n=875) had never experienced an overdose, 13.7% (n=114) noted that 
in the past 6 months they had experienced an overdose at least once. According to respondents, the key 
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cause of  overdose was heroin (54.6%) and desomorphine (20.5%). The percentage of  users who had 
heard of  Naloxone (an opiate/ opioid antagonist) was high 88.1% (n=1,522); however, the number of 
respondents reporting ever using naloxone during an overdose was rather low at 18.8% (n=318).
4.3.2. Data from Bio-Behavioural Surveillance Survey (BSS)
As previously noted, the Bio-behavioral Surveillance Surveys (BBSS) are conducted in Georgia once every 
two years. This chapter describes characteristics of  respondents for the 2014 BBSS.
A cross-sectional study of  people who inject drugs (PWID) used the respondent–driven sampling method 
(N=2,037). The percentage of  female respondents was low 2% (n=41). The median age of  respondents 
ranges from 37 to 42 years, with the majority belonging to the “41+” age group. The proportion of 
married respondents differed across cities (ranging from 33.6% - 56.5%). The majority of  respondents 
(69%) were unemployed (as was the case for the 2009 and 2012 surveys). The age of  initiation of  drug 
use was similar to findings from 2012; the median age of  first non-injecting drug use was 15-16, and 18-20 
for injecting drug use. 
Less than 6% of  respondents reported consuming alcohol on a daily basis within the past 30 days in all 
cities, except Telavi where 5.8% reported daily alcohol intake. Tbilisi had the lowest prevalence of  weekly 
alcohol consumption (7.1%), while Kutaisi had the highest with 16.3%.
Similar to findings from the 2012 study the most prevalent non-injecting drugs used during the past 30 days 
were cannabis and CNS depressants. 72.5% of  the respondents (n=1,476), who reported non-injecting 
drug use (including baclofen, pregabalin, gabapentin and others, 69%); almost half  of  the respondents 
reported using hallucinogens. Ten percent of  respondents reported using the new synthetic psychoactive 
substances referred to as “bios” (synthetic/bio-cannabis, crystal, or bath salts).
Injecting drug use had changed significantly from 2012. In 2012, heroin use was quite low at (35.9%) 
by 2014 the level of  use had increased to 58.1% returning to 2008-2009 levels. Similarly, non-medical 
consumption of  buprenorphine increased from 2012 and reached to 26%. It is noteworthy that the use of 
homemade injecting drugs (e.g. desomorphine and ephedrine) declined 2012 (See Figure 4).
Figure 4:  Past 30-day prevalence rates of  injecting drug use in 2008-2009, 2012 and
2014-2015 among BBSS respondents (Curatio International Foundation & Medical-Psychological 
Center “Tanadgoma”, 2015)
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In all cities heroin was the most frequently injected drug ranging from 45.1% in Rustavi to 67.6% in 
Batumi. There are differences in prevalence of  other drugs; for instance, injecting use of  buprenorphine 
in Gori was 13.4% whereas in Batumi it is 44%. 
Significant differences were also noted between cities in terms of  overdose rates. The proportion of 
respondents who experienced an overdose in the past 12 months ranged from a low of  5.6% in Rustavi 
to a high of  11.8% in Kutaisi. 
The proportion of  respondents who had never been treated for drug dependence ranged from a low of 
63.3% in Batumi to 85.6% in Gori. At 14.7%, Batumi leads in terms of  number of  people who inject 
drugs (PWID) who had been engaged with a specialized treatment facility in the past 12 months. 
The BBSS research report defines preventive program coverage as participants’ knowledge about HIV 
testing possibilities, receipt of  sterile injecting drug paraphernalia and/or condom distribution during 
the previous 12 months. Minimum coverage of  preventive program was defined as follows: a service 
user knows where to take the HIV test and has received at least one of  the following products: sterile 
injecting equipment, condoms, brochure/leaflet/booklet on HIV/AIDS, and qualified information on 
HIV/AIDS. 
According to study results, composition of  preventive packages differed across cities, with the highest 
program components coverage found in Gori. For instance, sterile syringes/needles were received by 
approximately a third of  Gori respondents (30.1%). Full service coverage of  the target population ranged 
from a low of  8% in Telavi to a high of  26.4% Gori. In general, coverage with preventive programs in the 
cities and towns studied was lower than the recommended minimum coverage.
One fifth of  respondents (22.1%) in Tbilisi noted that they were aware of  information about the syringe/
needles programs. It should be noted that the population studied were more knowledgeable about the 
methadone program (91.4% in Telavi and 99.7% in Zugdidi) than about the clean syringe/needle programs. 
According to the study, less than half  of  respondents (42.5%) stated that they injected drugs away from 
their place of  residence in the previous year.  The percentage of  respondents who reported injecting 
drugs in another country varied greatly from city to city with the lowest rate among Tbilisi respondents 
at 29.4% with highest rates among, Batumi respondents 62.1%. The most frequently named country was 
Turkey (79.5%), followed by Russia (6.1%), Azerbaijan (5.9%), the Ukraine (5.2%), and other countries 
(3.3%). 
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5.1.  INTRODUCTION
The country made significant strides in the past three years in terms of  creating institutional mechanisms 
for collection of  information on treatment demand indicators. Namely, in 2013 the National Centre for 
Disease Control and Public Health (NCDC) designed a special data collection form, which contains questions 
about sex and age of  patients admitted to drug dependence clinics, number of  primary and secondary 
admissions, drug administration routes, primary drugs use and poly-drug use. In 2014 the form was 
refined based on the EMCDDA treatment demand indicator form; the ranking of  age groups has changed 
and information about source of  referral and data on patients with alcohol problems were added to 
the form. In 2015 NCDC prepared a package of  amendments to the Order No. 01-27/n (Maintaining 
and Delivering Medical Statistical Information) of  the Ministry of  Labor, Health and Social Affairs of 
Georgia; which requires addiction treatment clinics to deliver monthly data to the NCDC on treated 
patients with substance use disorders. Based on these changes, future Drug Reports will contain more 
thorough information on treatment demand indicators. 
Information provided in this Chapter is based on information provided by the National Centre for Disease 
Control and Public Health, as well as the Report on Addictology Treatment Standards prepared in 2015 
through the TEMPUS project, aimed at developing institutional mechanisms of  addictology education 
(Addictology Standards in Georgia. 2015).
5.2.  TREATMENT STRATEGY AND POLICY
The strategy for treatment of  substance use disorders is prescribed by the State Strategy on Combatting 
Drug Abuse (State Strategy on Combating Drug Abuse, 2014); it contains strategic objectives including 
the provision of  evidence-based treatment for meeting the medical, psychological and social needs of 
people with substance use disorders and accessibility of  harm reduction services in addition to provision 
of  treatment, rehabilitation and harm reduction for prison inmates. Strategy notes that it is necessary to 
develop treatment and rehabilitation infrastructure, and raise relevant professionals. Focus is made on 
creating institutional mechanisms for ensuring quality of  treatment. In addition, it distinctly speaks about 
necessity of  creating institutional mechanisms of  alternatives to punishment for drug users. 
5.3.  TREATMENT SYSTEM AND ITS ACCESSIBILITY
The Law of  Georgia on Drugs, Precursors and Narcological Aid (the Law) regulates addiction treatment and 
establishes treatment and rehabilitation program funding sources, rules and conditions, - including the 
voluntary nature of  addiction services and patient confidentiality and anonymity rights. Article 34/5 of 
5.  ADDICTION TREATMENT
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the Law determines types of  mandatory medical assistance for people with drug addictions - including 
provision of  addiction services in temporary detention or penitentiary facilities and treatment in prison 
and liberty deprivation institutions. 
Pursuant to Articles 34-37, treatment in hospitals shall be delivered in accordance with approved or 
recognized national recommendations (guidelines) on clinical practice and state clinical condition 
management standards (protocols). 
Types of  services available in Georgia for individuals with drug related problems are as follows:
•	 abstinence-oriented treatment (detoxification) followed by short-term rehabilitation in a hospital,
•	 substitution therapy (e.g. opioid substitution therapy - OST)
•	 harm reduction services 
•	 several psychosocial rehabilitation Programs, (these are still at the level of  development)
Addictology services may be rendered by any legal entity working on prevention, diagnostics, treatment, 
rehabilitation and palliative care in Georgia (Government Resolution No 385, 17.12.2010, Government 
of  Georgia, 2010).
Drug treatment, rehabilitation and harm reduction services are provided by non-governmental, 
governmental and also private institutions. Financing of  addiction treatment is diversified. For example, 
there are three funding sources of  opioid substitution therapy (OST) 1.) the Global Fund Project, 2.) 
the state substitution program, and 3.) direct out of  pocket patient payment. The costs associated with 
abstinence oriented treatment are partially covered by the state in limited amounts or paid by the patient 
themself. Currently, neither the state universal health insurance nor private insurance mechanisms cover 
addiction treatment. For more detailed information see Table 4.
                                                                                                                                                   
Table 4: Legal Status of  the Treatment Facility and Funding Sources
Legal status of  the 
service provider
Funding Source
a. International (Global 
Fund for combatting 
AIDS, TB and Malaria)
b. Fully covered by 
patients (out-of-pocket)
c. Fully covered by the state 
budget
d. Co-payment (State budget 
and individual payment)
OST
Abstinence-
oriented treatment OST
Abstinence-
oriented 
treatment
OST
Abstinence-oriented 
treatment OST
Abstinence-oriented 
treatment
Public YES NO NO YES YES YES YES NO
Private YES NO YES YES YES YES YES NO
Harm reduction and psychosocial rehabilitation are mainly delivered by NGOs.
5.3.1. Abstinence-oriented treatment
Pursuant to Georgian Law abstinence-oriented treatment may be provided by any medical institution that 
has a permit to perform “hospital activities” and has a minimum of  three certified doctor-narcologists. 
Before 2010 narcological clinics had to have licenses issued by the Ministry of  Labour, Health and 
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Social Affairs Medical Activities Regulating Agency. This requirement was annulled after 2010, following the 
Government Resolution No 385 of  December 17, 2010 (Government of  Georgia, 2010). The Resolution 
regulates issuance of  the medical activities license and corresponding conditions, as well as issuance 
of  permits for maintenance of  “hospital activities” (in-patient clinics), corresponding procedures and 
conditions. This permission is enough to operate an in-patient addiction clinic.
Internal operational standards exist and are applied by all treatment facilities, be it an outpatient or in-
patient facility. Internal standards cover treatment plans for all nosological units (diseases) in accordance 
with the 10th revision of  International Classification of  Diseases (ICD-10). Here, the following are 
described for diagnoses F11-F19: standard tests, necessary consultations and procedures and a list of 
medication used by the clinic during application of  the relevant addiction treatment method. This serves 
as the basis for each clinic’s service pricing and associated mandatory financial documents. 
In 2008 a unified state program price formation standard was created that covers only two nosological 
units (F11 and F15) and is identical for all clinics. This standard includes 9 days of  hospital detoxification 
treatment followed by 5 days of  in-patient primary medical rehabilitation (in total 14 in-patient days) 
which are followed by additional 14-days of  outpatient rehabilitation. 
At the moment of  drafting this report, 6 clinics in Georgia provided abstinence-oriented treatment; with 
5 of  them located in Tbilisi and 1 in Batumi (for more details on clinics see Annex 2: Information on the 
treatment institutions).  Two out of  6 clinics are state run and 4 are private. Five out of  six clinics receive 
state funding in the framework of  the State Program for Treatment of  Drug Dependence; it allows clinics 
to render free services to a limited number of  patients. Overall, approximately 300 people annually receive 
state-funded treatment, but the rest (the majority) pay for treatment out of  their pockets.
According to the Government Resolution No 279 from 31, January 2013, the cost of  inpatient detoxification 
shall not exceed 1,250 GEL (550 €); and the primary rehabilitation cost shall remain in the limits of  1,000 
GEL (440 €). Priority is given to funding for the most vulnerable groups such as HIV/AIDS patients, 
socially vulnerable families, and patients 18-25 years of  age and those who have not yet been engaged in 
a treatment program. Similar to 2013, the cost of  inpatient abstinence oriented treatment in 2014 cost 
1,500-2,250 GEL and outpatient treatment cost 1,200-1,500 GEL (537-660 €). 
All six clinics provided 2014 data on treated patients to the National Centre for Disease Control and Public Health 
(NCDC). According to the data, 663 people completed inpatient abstinence-oriented treatment in 2014, 
of  which 1.8% (n=12) were women. The overwhelming majority of  patients (95.6%) were in treatment 
for the first time in 2014; with just 4.4% in repeated treatment. Seventy-seven percent of  patients self-
referred to clinics, 19.7% were sent from an opiate substitution therapy (OST) Program, and 3% were 
referred by other means. Information on the distribution for sex and age of  patients in treatment for 2014 
are presented in Table 5.
Table 5: Age and sex distribution of  patients treated in 2014 (Gamkrelidze et al. 2014)
Age Groups
Total Number (N=663) and Percentage
Men (n = 651) Women (n = 12) Total (N=663)
15-24 60 (9.2%) 0 (0%) 60 (9.04%)
25-34 228 (35%) 2 (16.6%) 230 (34.7%)
35-44 280(43%) 6 (50%) 286 (43.1%)
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45-54 71 (10.9%) 4 (33.3%) 75 (11.3%)
55-64 10 (1.5%) 0 (0%) 10 (1.5%)
64< 2(0.3%) 0 (0%) 2 (0.3%)
Total 651 (98.2%) 12 (1.8%) 663 (100%)
In both years treatment clients most often reported opioids as principal drugs of  abuse. At the same time, 
the number of  people receiving treatment for addiction to other non-opioid sedatives also increased (see 
Table 6).
Table 6: Primary drugs consumed by patients in the abstinence-oriented treatment Programs in 
2013 and 2014, in percentages (Gamkrelidze et al. 2014)
Most commonly used drugs   2013 2014
Heroin  49.7% 15.8%
Opium  0.3% 6.8%
Desomorphine 16.2% 9.8%
Buprenorphine 0.7% 8.9%
Methadone 14.9% 14%
Other opiates  0.7% 7.3%
Cocaine 0.5% 1%
Methamphetamines/ Amphetamines (not 
homemade)                             - 1%
Homemade stimulants  6.1% 10.6%
Benzodiazepines                     - 1.8%
Barbiturates                            - 0.6%
Other sedatives 4.8% 16.3%
Cannabis based preparations                     0.2%                                1.1%
Poly-drug abuse 5.2% 5.0%
5.3.2. Opioid Substitution Therapy (OST)
At the time of  writing this report, two types of  opioid substitution therapy were offered in Georgia: 1.) 
methadone substitution therapy and 2.) Buprenorphine based medication – combination of  buprenorphine 
and naloxone (Suboxone®). 
The legal basis for OST was created in 2002 with the adoption of  the Law of  Georgia on Drugs, Precursors 
and Narcological Aid. The first OST Program began functioning with support from the Global Fund to 
fight AIDS, Tuberculosis and Malaria in 2005. This modality of  treatment has developed fairly quickly. 
In 2009 the Order No. 37/n of  the Ministry of  Labour, Health and Social Affairs On Implementation of  the 
Substitution Therapy Programs in Opioid Drug Addiction developed an OST treatment framework including 
methodology, patient enrolment criteria, and discharge conditions. On 3, July 2014 this order was 
amended by the Ministry (Order No. 01-41/n), which concerned implementation of  OST Programs in 
extraordinary circumstances (for instance, at the time of  patient hospital admission, participating in the 
program, etc.), and the list of  opioids and other medications approved for use in OST. 
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Today, in Georgia OST is being carried out utilizing three different funding mechanisms; the Global Fund 
Project, State Substitution Therapy Program, and private funding. 
The State Program is based on the co-payment principle. The state covers the cost of  methadone (from 
the budget of  the State Addiction Treatment Program), and the patients cover the cost of  associated services, 
(110 GEL/48 €) per month. The Government Resolution No. 279 (31 January 2013) regulates cost of 
the treatment voucher. Co-payment does not apply to HIV-positive individuals and persons below the 
poverty line who are entitled to free treatment. The state funds 1,800 beneficiaries monthly; 110 of  them 
received combined buprenorphine/naloxone medication. Thirteen State Opioid Substitution Therapy Programs 
function in various regions of  Georgia; 7 of  them are in Tbilisi, and one in each of  following cities: Poti, 
Kutaisi, Batumi, Zugdidi, Ozurgeti and Telavi. 
A private Suboxone® substitution treatment Program has been functioning in Tbilisi since 2012. In 2014, 
275 men and 3 women participated in the Program. Age distribution of  patients in 2014 was as follows: 
43% belong to the 35-44 age group, 40% to the 25-34, 13% - 45-64, 2% - 15-24 and 2% belong to the 
55-64 age groups. As of  2016, patients pay 28 GEL (12 €) per visit. 
The Global Fund (GF) Project provides free of  charge OST for patients participating in the Program. 
Four substitution therapy centres function here with two of  them located in Tbilisi, one in Gori and one 
more in Batumi. In 2014 in total 3,968 people received Opioid Substitution therapy in Georgia, out of 
them 49 were women (See Figure 5).
Figure 5: Number of  patients who received OST and abstinence-oriented treatment10 
(Gamkrelidze et al. 2014)
 
Short-term methadone detoxification is carried out in two correctional facilities of  Tbilisi and Kutaisi 
(No. 2 and No. 8) with support from the Global Fund. In 2014, 474 inmates (including 4 women) utilized 
these services. Correctional Facilities Numbers 2 and 8 implemented methadone detoxification programs 
in cooperation with the Centre for Mental Health and Prevention of  Addiction with support from the Global 
Fund.
10 Note: data for 2012 detoxification treatment are not available
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5.3.3. Psychosocial Rehabilitation
Psychosocial rehabilitation of  people with substance use disorders is at the initial stage of  development 
in the country. Therapeutic communities have not been established yet, and existing psychosocial 
rehabilitation is primarily aimed at providing non-medical treatment. The Global Fund financed three 
outpatient psychosocial rehabilitation centers: Kamara, Psychosocial Rehabilitation Centre of  Patriarchy and the 
Rehabilitation Unit of  the Centre for Mental Health and Prevention of  Addiction. The centers serve patients 
included in substitution therapy and abstinence-oriented treatment as well as former drug users. Clients are 
offered individual, group and family therapy, ergo and art therapies, computer classes, religious activities, 
peer-to-peer support, etc. Rehabilitation centers also offer HIV voluntary testing and counseling services. 
The combined maximum capacity of  all three centers is 300 people. 
Supporting employment of  people with substance use problems remains a challenge. To address this gap, 
in 2014, the International Organization for Migration (IOM) initiated a pilot employment and social enterprise 
project for the purpose of  social reintegration of  people who use drugs and are engaged in psychosocial 
rehabilitation (for more details see 8.2 Social Reintegration).
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6.1.  INTRODUCTION
Sources of  information on drug use related healthcare correlates and consequences are diverse. Institutional 
mechanisms for collecting and processing HIV/AIDS data are well developed due to creating and enacting 
a special governmental institution –Infectious Diseases, AIDS and Clinical Immunology Research Centre (AIDS 
Centre) – in the 1980s, right after beginning of  the HIV/AIDS epidemic globally. Little information is 
available on non-lethal drug overdoses, or drug-related deaths and mortality. One of  reasons is that after 
the break-up of  the Soviet Union the data collection institutional mechanism was temporarily dysfunctional 
and was renewed only several years ago. Stigma is another reason because of  which, traditionally, Georgian 
families try to conceal death caused by drugs. The third reason is unfavourable environment for overdose 
registration, which existed until 2014. Prior to this doctors called to cases of  overdose had an obligation 
of  reporting to police the use of  drugs for non-medical reasons; which had been a significant barrier 
for seeking help. The 2014 legislative amendment abolished this obligation; it is expected that it will be 
followed by an increased trend in seeking help due to drug overdose as well as detection and improvement 
of  registration of  overdose episodes. 
6.2. DRUG RELATED INFECTIOUS DISEASES
6.2.1. Newly Registered HIV/AIDS Cases
As of  31, December 2014, 4,695 cases of  HIV/AIDS were registered in Georgia. In 2014, 84 AIDS 
related deaths and 564 new HIV cases were registered in the country. The incidence rate of  HIV/AIDS 
is 15.1 per 100,000 citizens, which exceeds the rate for 2013 by 38.5%. The ratio of  newly detected cases 
is 3:1 for men and women. Newly detected infections among people 25 years and younger accounted for 
9.4% of  all cases in 2014. (See Figure 6).
Figure 6: Annual incidence of  HIV/AIDS (newly identified cases) for 
2005-2014 per 100,000 inhabitants (Chkhartishvili and Chokoshvili 2015)
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Historically, injecting drug use was the leading reason for expansion of  the HIV epidemic in Georgia, but 
as of  2010 the situation has changed and shifted towards heterosexual contacts. In 2014, the proportion 
of  injecting drug use among newly registered cases declined to 34%, and the proportion of  heterosexual 
contacts increased to 52.8% (see Figure 7). 
Figure 7: HIV transmission routes, 2012-2014, in % (Gamkrelidze et al. 2014)
Late diagnosis of  HIV has been a serious problem in Georgia - 35.6% of  newly diagnosed HIV cases are 
manifested at the AIDS stage. To control HIV spread among general population, State Program on HIV/
AIDS conduct HIV tests of  pregnant women, blood donors, various high-risk populations and other 
groups, including defendants and inmates.
In 2014 the Georgian Harm Reduction Network (GHRN) conducted 20,544 HIV tests for individuals utilizing 
the harm reduction programs. Out of  the 20,544 tests, 91 tested positive for HIV and 52 cases were 
confirmed HIV-positive through follow-up testing. Note that the other 39 clients’ status is unknown 
as not all results of  confirmatory testing are reported back to the GHRN. A series of  consultations 
accompanying tests was delivered: 20,543 pre-test and 20,538 post-test consultations and another 54 
consultations were rendered following confirmation.
According to the Infectious Diseases, AIDS and Clinical Immunology Research Centre, the number of  HBV/HIV 
registered co-infections in 2014 was 33, of  which 27% (n=9) were IDUs. There were 177 newly registered 
HCV/HIV co-infection cases, out of  which 70% (n=124) were injecting drug users. An additional 9 
patients, who were dually infected with HBV/HCV and also HIV-positive, were registered; 44% (n=4) of 
whom were injecting drug users (Chkhartishvili and Chokoshvili 2015).
6.2.2. Seroprevalence of  HIV 
Bio-behavioral Surveillance Survey (BBSS) on IDUs has been conducted regularly from 2002 in Georgia. 
The most recent survey has been conducted in 2014 (see chapter 4). The research covered 7 cities of 
the country: Tbilisi, Rustavi, Gori, Telavi, Zugdidi, Batumi and Kutaisi. The survey showed that HIV 
Figure 7: HIV transm ission routes, 2012-2014, in % (Gamkrelidze et al. 2014) 
 
 
 
Figure 8: HIV prevalence am ong IDUs, 2014(Curatio International Foundation & Bemoni Public Union 
2015b) 
 
 
 
 
 
0
10
20
30
40
50
60
70
2007 2008 2009 2010 2011 2012 2013 2014
%
injecting drug use
heterosexual contacts
same sex contacts
blood transfussion
mother-to-child
unknown
4.6
2.9
4.6 5
5.3
7.8
11
0 0 0 0.4
0.5
1.8
0.2
0.9 1.2
2 2.4
2.6
4.4 4.8
0
2
4
6
8
10
12
Rustavi Telavi Tbilisi Gori Kutaisi Batumi Zugdidi
%
THE DRUG SITUATION IN GEORGIA 33
prevalence among IDUs differs from town to town with the lowest prevalence in Rustavi (0.9%) and the 
highest in Zugdidi (4.8%) (Confidence interval 95% Cl, 0.2%-11%) (See Figure 8).
Figure 8: HIV prevalence among IDUs, 2014 
(Curatio International Foundation & Bemoni Public Union 2015b)
The Survey detected that HIV prevalence is higher in IDUs of  40 years old and above (see Table 7).
Table 7: HIV prevalence by age groups 
(Curatio International Foundation & Bemoni Public Union 2015b)
Age Groups Percentage
Number out of 
Total Age Group 
Sample N 
18-24 0.6 1/162
25-30 1.3 4/302
31-40 1.7 11/642
41 and older 3.1 28/916
All Ages 2.2 44/2022
Based on combined analysis of  7 towns the mean HIV prevalence was 2.2% (95% Cl 1.53-2.99); this 
figure does not significantly differ from that of  2012, which was  3% (95% Cl 2.20-4.04).
Figure 9 shows the HIV prevalence in cities by year for 2009, 2012, and 2015 (see Figure 911). The 
indicator for Tbilisi has not changed since 2009 and remains below 5%. The situation is alarming in 
Batumi and Zugdidi. Batumi retains a high HIV prevalence since 2009 and in Zugdidi HIV prevalence 
has increased since 2009. In both cities relatively high prevalence among IDUs increases the risk for the 
spread of  HIV infection in the general population. In Kutaisi and Gori indicators are on the same level, 
but it has increased since 2009 in the latter. In Rustavi, where the Survey was first conducted in 2015, the 
HIV infection prevalence is the lowest among all cities participating in the survey.
11 Figure shows average weighted, i.e. indicator calculated per population. Since similar analysis is conducted from 2009, the diagram 
shows data for 2009-2015
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Figure 9: HIV prevalence of  HIV/AIDS among IDUs, 2009-2015 by cities
(Curatio International Foundation & Bemoni Public Union 2015b)
6.2.3. Other Drug Related Infections
Viral Hepatitis 
Based on existing data, Georgia belongs to a category of  countries with high Hepatitis C (HCV) prevalence. 
It has been influenced by various factors like: collapse of  the healthcare system in 1990s, insufficient 
quality standards at treatment facilities, which facilitated practice of  unsafe injectings; lack of  infection 
control and blood safety in the healthcare system; practice of  sharing syringes between injecting drug 
users, etc. (Gamkrelidze et al. 2014).
Over the past several years the Georgian government made important steps to combat Hepatitis C; for 
instance: initiating free National Program for HIV/HCV co-infected patients (funded by the Global Fund 
as of  2011 in the frame of  the HIV Program), free treatment of  Hepatitis C for prison inmates, and 60% 
discount for general population on ribavirin and pegylated interferon combination. 
In February 2014 together with the US Centre for Disease Control the Ministry of  Labor, Health and Social 
Affairs (MoLHSA) started working on National Strategy for Hepatitis C Elimination and the Action Plan 
thereto. Immediate (short-term) strategy is already put to action and the long-term strategy is being 
developed (2015-2020). Simultaneously, the Government of  Georgia started negotiations with Gilead 
pharmaceutical company, a global leader producing direct and highly active anti-viral medication, includ-
ing Sofosbuvir and Ledipasvir/Sofosbuvir fixed dose combination. The Memorandum of  Understanding 
(MOU) between Gilead and the Georgian government was signed on 12 April 2015, which is a necessary 
condition for providing persons in need of  treatment with pharmaceutical products. The Table below 
shows dynamics of  changing medication used for treatment of  Hepatitis C in Georgia.
Figure 9: HIV prevalence of HIV/AIDS am ong IDUs, 2009-2015 by cities (Curatio International 
Foundation & Bemoni Public Unio  2015b) 
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Table 8:  HCV anti-viral treatment available in Georgia (National Centre for Disease Control and 
Public Health of  Georgia 2015a)
Treatment Treatment Year
Interferon alpha monotherapy 1996
Interferon alpha + ribavirin 1998
Pegylated interferon alpha 2001
Pegylated interferon alpha + ribavirin 2002
Pegylated interferon alpha + ribavirin + telaprevir or boceprevir 2011
Sofosbuvir + pegylated interferon alpha + ribavirin 2014
Sofosbuvir + ribavirin 2014
Sofosbuvir + ledipasvir 2015
Sofosbuvir + daclatasvir 2015
Ombitasvir + paritaprevir + ritonavir + dasabuvir 2015
As to the spread of  HCV in the general population, the National Centre for Disease Control and Public Health 
had conducted the cross-sectional HCV sero-survey using stratified, multi-stage cluster design with 
random sampling of  the general population of  Georgia in May-August of  2015. In total 6,330 people 
completed survey interviews and 6,012 blood samples were collected and analyzed.  Results of  the survey 
enable us to estimate with statistical confidence, the scale of  Hepatitis C spread in the general population, 
and among IDU’s. According to preliminary data, 7.1% of  the studied population was anti-HCV positive, 
and 5.16% were HCV RNA positive. Final results on HCV and HBV prevalence and incidence will be 
described in the next Drug Report.
According to data of  the Georgian Harm Reduction Network (GHRN), the main provider of  low-threshold 
services to injecting drug users, 14,411 program beneficiaries were tested for HCV using rapid, simple 
testing in 2014, out of  which 46.9% (n=6,751) were HCV positive (See Figure 10).
Figure 10: Hepatitis C testing of   IDUs, GHRN programs’ clients (Gogia 2014)
In 2014 the Georgian Harm Reduction Network had also conducted 8,122 Hepatitis B tests (HBsAg) among 
GHRN Programs beneficiaries and 8.8% (n=716) were HBV positive (See Figure 11).
Figure 9: HIV prevalence of HIV/AIDS am ong IDUs, 2009-2015 by cities (Curatio International 
Foundation & Bemoni Public Union 2015b) 
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Figure 11: Number of  Hepatitis B tests and positive cases among IDUs (Gogia 2014)
According to the results of  the 2014 Bio-behavioral Surveillance Survey (See Sub-chapter 6.2.2) in 7 
surveyed cities, the pooled HCV prevalence rate was 66.2%. High HCV prevalence was found in Batumi, 
Kutaisi, Tbilisi, and Zugdidi. Surveys of  previous years showed the same high prevalence rate for those 
cities, which may mean that injecting drug users did not exercise safe injecting practices in the beginning 
of  their IDU career. Currently the highest prevalence is identified in Batumi and the lowest in Telavi (see 
Figure 12).
Figure 12:  HCV prevalence among IDUs 
(Curatio International Foundation & Bemoni Public Union 2015b)
Syphilis
In 2014, 1,431 new cases of  syphilis were registered in Georgia. The incidence rate among all age groups 
was 38.4 per 100,000 citizens, which shows an increased incidence compared to previous years (See 
Figure13).
Figure 11: Num ber of Hepatitis B tests and positive cases am ong IDUs (Gogia 2014) 
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Figure 13: Syphilis incidence per 100,000 persons in 2012-2014 (Gamkrelidze et al. 2014)
Data on the number of  IDUs among individuals identified as being infected with syphilis is unavailable. 
The Bio-Behavioral Surveillance Survey of  2014 did not include information on tests for syphilis. There-
fore, we can only discuss syphilis using data from the Georgian Harm Reduction Network (GHRN) 
(Gogia 2014), which has regularly (annually) carried out RPR (Rapid Plasma Reagin) testing among its 
program’s beneficiaries since 2010. In 2014, 10,149 RPR tests were performed, of  which 4.8%  (n=490) 
were RPR-positive (See Table 9). 
Table 9: Syphilis among IDUs – number of  tested and positive cases by years (Gogia 2014)
2010 2011 2012 2013 2014
Number of  tests for syphilis (RPR) 523 344 1,622 4,759 10,149
RPR prevalence  % 0 0 3% 4% 4.8%
Tuberculosis
According to data of  the Georgian Harm Reduction Network, in 2014, 4,075 TB tests were performed for 
IDUs participating in their Programs; 396 (9.7%) of  them had positive results. Based on that they were 
referred to specialized medical facilities and 33 of  them were enrolled into the National TB program.
6.3. OTHER DRUG-RELATED MORBIDITY
6.3.1. Non-lethal Overdose 
It was determined that the State will begin the collection of  information on non-lethal drug overdoses 
in accordance with ICD codes (F10-F19) in 2015 using statistical form IV-11, designed for this purpose, 
by the National Centre for Disease Control and Public Health (NCDC) in 2013 (National Centre for Disease 
Control and Public Health of  Georgia, 2015b) . 
The Annual Drug Report for 2013 contains information on two surveys conducted by the Georgian Harm 
Reduction Network (GHRN) on non-lethal overdose of  their patients and beneficiaries, relevant knowledge 
and skills, and corresponding preventive activities (Gogia 2013).
Figure 13: Syphilis incidence per 100,000 persons in 2012-2014 (Gamkrelidze et al. 2014) 
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According to information of  the Ministry of  Internal Affairs, in 2014 5 persons were fined due to driving 
under influence of  drugs or other psychotropic substances (Article 116 of  Administrative offences of 
Georgia); and 1611 persons were fined after resulting injuries for other persons, impairing other vehicles 
or traffic facilities as a result of  driving under influence (Ministry of  Internal Affairs of  Georgia, 2014). 
6.4.  DRUG RELATED DEATH AND MORTALITY
Collecting information on drug related death cases was stopped in the 1990s and was reinstated in 2007 
by the Levan Samkharauli National Forensic Bureau12.
Table 10: Registered drug related death cases
(Levan Samkharauli National Forensic Bureau, 2015)
Year Registered overdoses
2010 16
2011 16
2012 39
2013 28
2014 7
The number of  documented overdose deaths is small and does not correspond to informal data from 
Harm Reduction Services and data from the Georgian Harm Reduction Network’s surveys (See GHRN 
Annual Report, 2015 and section 7 of  this report). It may be assumed that legislative environments 
were an obstacle to obtaining accurate information. The Special Order of  the Minister of  Labor, Health 
and Social Affairs No. 239/n (MoLHSA, 2000), obliged eye-witnesses (or those assisting) in overdose 
cases to inform police, which hindered collection of  information. Data prior to 2010 is unavailable. As 
previously mentioned, in the introduction of  this section on health correlates, the mandate to inform law 
enforcement was lifted in 2014, and doctors are no longer obligated to inform police (except in cases 
where signs of  other crimes are evident). This change in policy has helped create favorable conditions for 
collecting more accurate data in 2015. 
12 For the present report, the number of  drug-related overdose cases were confirmed in 2015; as a result, the numbers reported 
differ from those indicated in the 2013 report.
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7.1.  INTRODUCTION
Harm reduction is the most developed approach in response to drug addiction problems in Georgia. 
The country began acting to stop the spread of  the HIV/AIDS epidemic in 1980s. For this reason, with 
support of  the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) and other international 
donors, harm reduction-oriented measures and relevant infrastructures have been developed in the country. 
Georgian Harm Reduction Network is an important part of  this infrastructure. Its’ member organizations 
work both in the capital city and regions across Georgia on prevention of  drug related death and blood-
transmitted infections among injecting drug users. 
As of  2014, development of  institutional mechanisms for eliminating Hepatitis C began in Georgia, and 
the Emergency Action Plan for Hepatitis C was being implemented. As of  the writing of  this Report the Long-
term Hepatitis C Elimination Program Action Plan for 2015-2020 was still under development (See subchapter 
6.2.3).
7.2. PREVENTION OF DRUG RELATED EMERGENCY SITUATIONS 
AND DEATHS
Data on drug related medical emergencies and death are scarce in the country (See sub-chapters 6.3 and 
6.4). At the same time, Georgian Harm Reduction Network documented 528 cases of  drug overdose. The 
largest number of  overdoses were observed in Batumi (28%) and Rustavi (28%), followed by Sukhumi 
(12%) and Tbilisi (11%). These data were collected by the “Take Home Naloxone” project, which has 
been in operation since it was implemented in 2009 with financial support of  the Global Fund for 
beneficiaries of  the HIV prevention program. The goal of  this project is to prevent death of  PWID due 
to overdose. The project conducts trainings to facilitate raising awareness and create adequate response 
skills among PWID. An important component of  the project is distribution of  naloxone ampoules to 
PWID. According to information about the 2014 number of  used naloxone ampoules; which were used 
as a result of  naloxone injecting, 93% (n=489 of  528) of  overdose cases survived with 7% (n=39) lethal 
overdose cases. No data on the type of  substances associated with the overdose cases are available. Table 
11 shows trends in distribution of  Naloxone ampoules in the frame of  the Program.
7. RESPONSE TO HEALTH CORRELATES 
AND CONSEQUENCES
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Table 11:  Trends of  naloxone ampoules distribution to PWIDs (Gogia 2014)
Years 2009 2010 2011 2012 2013 2014
Number of  ampoules 2,400 1,848 288 1,396 1,628 9,881
7.3. PREVENTION AND TREATMENT OF DRUG-RELATED 
INFECTIOUS DISEASES
With methodological and financial support of  international organizations, Georgia as well as civil sector 
organizations, are working on prevention and treatment of  drug related infectious diseases. Georgia has 
responded to HIV/AIDS and Hepatitis C with relevant state programs implemented by the public sector 
as well as non-governmental and private sector organizations. 
The goal of  the State HIV Prevention Program is to reduce transmission of  HIV/AIDS through early 
detection of  new cases and treatment. Universal access to antiretroviral treatment is provided in the 
framework of  the program. As of  2013 and according to new guidelines on HIV-infection treatment the 
antiretroviral treatment is recommended if  CD4 cell count is equal or less than 500; according to these 
guideline, early detection and engagement into treatment is one important means of  preventing further 
spread of  the disease.
The goal of  the first stage of  the Program of  the Ministry for Labor, Health and Social Affairs on Elimination 
of  Hepatitis C is to reduce morbidity, mortality and spread of  infection caused by Hepatitis C (HCV) by 
means of  gradual provision of  population access to prevention, diagnosis and treatment. The program 
supports the diagnosis and enrolment of  Hepatitis C patients into treatment with relevant medication 
(Sofosbuvir, pegylated interferon and ribavirin) appropriate to their qualifying medical criteria (e.g. liver 
fibrosis level). Treatment program eligibility includes the following: 1.) the person must be a citizen of 
Georgia with active HCV infection, 2.) they have a counter-indication to traditional PEG IFN and RBV 
Hepatitis C medication, 3.) they  have never been treated before, and 4.) if  they were previously treated 
their  treatment failed or was unsuccessful. For the diagnostic component of  HCV care, the state program 
envisages 70% co-payment by patients; this is reduced to a 30% co-payment by patients with a socially 
disadvantaged status. Medication is donated by the Gilead Sciences Inc. and is provided to beneficiaries 
for free. As of  the writing of  this report, during 2016, 6,000 individuals were engaged in this program. 
According to data of  the Infectious Diseases, AIDS and Clinical Immunology Research Centre, at the end of  2014, 
2,541 HIV/AIDS patients received antiretroviral (ARV) treatment; 1,094 individuals were infected via 
injecting drug administration. The 12-month survival rate for the entire infected population reached 86%, 
and was 83% among people who use drugs (Chkhartishvili and Chokoshvili 2015). 
With support from the Global Fund, HIV/AIDS testing and consultation became available to all 
penitentiary facilities. In 2014 the number of  inmates tested for HIV and Hepatitis C amounted to 8,000. 
Hepatitis C was diagnosed in 48% (n=3,800) of  those tested and HIV/AIDS in < 1% (n=34) (detailed 
information on the treated cases is presented in Chapter 5). 
Low-threshold services play a very important role in helping prevent dissemination of  drug-related 
infections; the Georgian Harm Reduction Network offers such services. The Network unites 26 
organizations and coordinates low-threshold activities in 11 towns of  Georgia through its 14 service 
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centers. Together with other activities, the low-threshold centers also distribute sterile injecting equipment, 
condoms and informational materials in the PWID community. Figure 14 shows the distribution of  clean 
injecting equipment per year from 2006-2014. 
Figure 14:   Number of  distributed needles and syringes by years (Gogia 2015)
Georgian Harm Reduction Network actively tries to increase geographic coverage of  the program as well as its 
scale; therefore they apply peer-driven interventions. As of  2015 they plan to introduce mobile outpatient 
voluntary counseling and testing services.
7.4.  RESPONSE TO OTHER HEALTH CORRELATES OF DRUG USE
Information on other drug use-related health problems and the response thereto is not currently col-
lected. The only available source of  information, where corresponding data may be found is Georgian 
Harm Reduction Network member-organizations. For instance, the NGO Tanadgoma provides mental health 
counseling to people who inject drugs (PWID) with psychiatric co-morbidities through a voluntary testing 
and counseling program  (Gogia 2014). In addition, with support from the French organization Medicine 
Du Monde the NGO New Vector provides free medical assistance to PWID. For instance, in 2014 the New 
Vector rendered dental services to 814 PWIDs, and the liver fibroscan examination to 910 PWIDs with 
Hepatitis C (Labartkava, 2015).
Figure 13: Syphilis incidence per 100,000 persons in 2012-2014 (Gamkrelidze et al. 2014) 
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8.1. INTRODUCTION
The first attempt to introduce psychosocial rehabilitation services in Georgia was made in 2012, but with 
limited success (Javakhishvili, Otiashvili, and Tabatadze 2013). In recent years psychosocial rehabilitation 
was removed from the policy agenda of  the MoLHSA. Psychological assistance for people with drug ad-
dictions, and rehabilitation and social reintegration interventions for PWID were very limited in Georgia. 
1. State expenditures of  rehabilitation services for PWID in 2014 were similar to allocations in previous 
years. According to Government Resolution No 650 (2, December 2014) that approved state health 
programs for 2014, a total of  1,600 GEL (704 €) per patient was allocated by the state for medical 
services to treat drug addiction. 
2. The state program also allocated funds for rehabilitation services for psychiatric and behavioral dis-
orders caused by psychoactive substances, and primary psycho-physical rehabilitation in the amount 
of   400 GEL (176 €). 
Within the framework of  the state program, patients who undergo short-term treatment and are dis-
charged from the clinic, are also entitled to receive counseling (free-of-charge) from medical narcologist 
and/or psychologists during a two week period on an outpatient basis. 
According to the data from the Ministry of  Justice of  Georgia (MoJ), starting from November 2012 
the LEPL Crime Prevention Centre of  the MoJ began social rehabilitation and reintegration programs for 
people who were formerly incarcerated. This was considered innovative because such programs had not 
previously existed in Georgia (Ministry of  Justice of  Georgia, 2015). However, the number of  inmates 
convicted for drug-related crimes who allegedly benefited from this program is unknown. In recent years, 
several donor-funded programs were initiated to facilitate the process of  social reintegration of  people 
who use drugs. A brief  description of  these programmatic activities is presented in section 8.2 Social 
Reintegration.
8.2. SOCIAL EXCLUSION AND DRUG USE
Data on social exclusion of  people who inject drugs (PWID) are insufficient. This Chapter presents social 
indicators of  people who use drugs, based on statistical data from the Bio-Behaviour Surveillance Survey 
(BBSS) of  problem drug users (Curatio International Foundation & Bemoni Public Union, 2015a).
In the 2014 BBSS, in total 2,037 drug users were surveyed in 7 cities of  Georgia; the majority (98%) were 
men. Among people interviewed for the study 95.5% were ethnic Georgians; this corresponds to the eth-
nic composition of  the general population of  Georgia. Currently, there are no data on drug use among 
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ethnic minorities since no specific research was conducted in ethnic minorities. Forty-five per cent of 
BBSS survey respondents reported to be internally displaced persons (IDPs). 
Marital status: almost half  of  respondents (45.3%) were married, and less than one-third of  the survey 
respondents (32.2%) had never been married. Almost one-fifth of  respondents (21.2%) were divorced 
or separated. Differences between cities were insignificant; the largest proportion of  married persons 
was found in Kutaisi and Batumi with 56.5% and 55.6% respectively. The lowest proportion of  divorced 
respondents lived in Zugdidi - 9.5%. 12.5% of  respondents lived alone. The largest percentage of  BBSS 
respondents who reported living alone were in Tbilisi (16.6%) and the lowest proportion reside in Zugdidi 
(7.2%). A small percentage of  respondents (1.4%) stated that they lived with partners, with 4% in Tbilisi, 
3% in Zugdidi and less than 2% in other cities. 
Education: The majority of  respondents (59.9%) had secondary or vocational education. Just over one 
third (35.5%) of  respondents in all cities had higher education. The highest number of  respondents with 
higher education was recorded in the capital city Tbilisi with 59.5% and the lowest in Zugdidi (27.6%). 
Very few respondents said they had never received any formal education (one respondent in Batumi and 
one in Zugdidi), or had only primary education (one respondent in Rustavi).  
Employment: More than two-thirds of  respondents (out of  2,037) were unemployed at the time the 
BBSS survey was conducted. The proportion of  unemployed across all seven cities equaled 69% which 
ranged from 51.3% in Gori to 73.2% in Kutaisi. The percentage of  respondents who were currently 
students was less than 1%. A large proportion of  employed problem drug users participating in the sur-
vey said that they had temporary jobs. Only 8.9% of  respondents had permanent paid jobs. The highest 
employment rate was in Telavi with 18.7% and the lowest in Zugdidi, where only 5.6% reported having 
a permanent job.  The BBSS conducted in 2012 (Curatio International Foundation and Bemoni Public 
Union, 2012) found the highest employment rate among participants in Zugdidi (13.6%) however the 
situation there has detiorated and by 2014  only  5.6% were regularly employed. 
Income: In all seven cities, the average monthly income of  people who use drugs was 100-300 GEL (44-
132 €); one fifth had monthly income less than 100 GEL (44 €). Sixteen percent of  respondents reported 
that their monthly income was 500-1000 GEL (220-440 €); and only 3.5% of  respondents earn more than 
1,000 (440 €) per month. (See Figure 15).
Figure 15:  Percentage of  PWID by monthly income in GEL/EUR
(Curatio International Foundation & Bemoni Public Union 2012)
 
 
 
Figure 16:  Num ber of individuals sentenced under Article 260 and 273 of CCG by years, 2007-
2014(Supreme Court of Georgia, 2015) 
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The data presented in Figure 15 indicate that PWID in Georgia belong to financially vulnerable groups: 
unemployment rates among drug users are 6 times higher than that of  the general population. According 
to data from the National Statistics Office of  Georgia, in 2014 the unemployment rate in the economically 
active population did not exceed 12.4%13, while more than two-thirds of  drug users surveyed (69%) re-
ported being  unemployed. 
Monthly income of  those employed is also significantly lower compared to the national income level in 
Georgia. According to official statistics the 2014 average monthly nominal salary of  hired employees was 
818 GEL (360 €)14, however more than 90% of  problem drug users surveyed earn less than the average 
monthly nominal salary. Furthermore, one-fourth of  all respondents earned less than the living wage 
(154.5 GEL/68€)15 necessary for an adult. 
There is no information about drug use problems among homeless people in Georgia. Specific research 
to examine the prevalence of  past or current drug use among homeless individuals has never been con-
ducted in the country. The first temporary shelter for people residing in the streets was established in De-
cember 2013 by the government to help homeless people survive cold winters. According to MoLHSA, 
about 170-190 homeless people sleep in the Tents Town shelters. The criteria to accept beneficiaries for 
this housing are simple - personal inquiry, or referral from a patrol police officer who identifies and takes 
a homeless person to the tents.16 The media published several cases of  alcohol intoxication among shelter 
residents.17 The professional community does not acknowledge that homelessness is a visible problem 
among drug users; however the problem of  alcohol or other drug use among homeless people in Georgia 
has not been studied and requires further examination. 
8.3. SOCIAL REINTEGRATION
A substantial portion of  the programs which aim to support social reintegration of  people who use 
drugs, are funded by international donor organizations. Since 2012 the LEPL Crime Prevention Centre of  the 
Ministry of  Justice has been working on rehabilitation and socialization of  formerly incarcerated people. It 
is presumed that some of  the formerly incarcerated people enrolled in this Program have been convicted 
for drug-related crime. However, disaggregated data about the beneficiaries by the type of  conviction 
is not available. Activities performed with donor assistance and programmatic data on beneficiaries are 
described in the following section.
Programme of  Social Enterprises of  the International Organization for Migration: 
As of  June 2014, the International Organization for Migration (IOM) Mission to Georgia in a close coop-
eration with IOM Berne and Swiss Foundation Contact Netz started implementation of  the Social Enter-
prises’ Programme. The programme is titled “Socio-Economic Integration through Social Enterprise Development 
to Address the Problem of  Drug Abuse among Georgian Nationals, Including Returning and Potential Migrants” and 
is supported by The State Secretariat for Migration of  Switzerland (SEM). The Programme aims to rehabilitate 
and integrate people in addiction recovery who have emigrated or intend to emigrate from Georgia. The 
goal of  this Programme is to help Georgia develop national capacities for socio-economic inclusion and 
13  http://www.geostat.ge/?action=page&p_id=145&lang=geo
14 http://www.geostat.ge/?action=page&p_id=145&lang=geo
15 http://www.geostat.ge/?action=page&p_id=178&lang=geo
16 http://humanrightshouse.org/Articles/20431.html,  accessed on March 14, 2015
17 Mindia Aptsiauri. Living a homeless life in Tbilisi shelter. January 13, 2014. http://www.georgianjournal.ge/society/25971-living-
a-homeless-life-in-tbilisi-shelter.html
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empowerment of  people with a history of  drug use as a sustainable solution to the drug abuse prob-
lem.  The Swiss Foundation Contact Netz which is an implementing partner of  IOM in the frames of  this project, has 
long-standing expertise in social entrepreneurship for the rehabilitation of  drug users and contributes by 
transfer of  Swiss know-how. 
During the inception phase of  this Programme, IOM established the Project Support Committee comprised 
of  relevant governmental stakeholders and international organizations. An open and inclusive grant com-
petition was held, which resulted in the establishment of  six social enterprises that are operated by five 
Social Enterprise Implementing Partners of  IOM. These enterprises employ the target group and offer to 
the latter six months’ duration therapy through work rehabilitation programme functional in the following 
scope of  economic activities:
•	 Nursery for decorative flowers, shrubbery and trees and organic (bio) vegetable farming as well as 
breeding of  animals, poultry and fish. The given Social Enterprise “Green Family” is operated by the 
Gori Sapling Nursery of  Gori Municipality. 
•	 Wooden (carpentry) workshop, which produces souvenirs, toys, and furniture and is operated by LTD 
Perspektiva under the National Probation Agency of  Georgia.
•	 Cafeteria and a Car Wash Service Social Enterprises operated by non-commercial organization 
“Change the Scenario”, which is a subsidiary organization of  the LEPL Centre for Crime Prevention 
under the MoJ.
•	 The Art Café Social Enterprise, which is operated by the NGO Kamara.
•	 Advertisement Studio for the production of  promotional materials, which is operated by the Centre 
for Information and Counseling on Reproductive Health Tanadgoma.
Throughout 2015-2016 social enterprises will offer long-term work rehabilitation services to a minimum 
of  120 people in drug addiction recovery. The Programme aim is to: a.) facilitate further integration of  its 
beneficiaries, b.) raise public awareness through campaigns to sensitize potential employers and the public 
about the beneficial impact of  integration services, and c.) disseminate information about the workforce 
capacity of  programme alumni and raise employers’ sensitivity towards the importance of  former drug 
users’ integration. This will contribute to overcome existing stigma among the general population and 
stimulate interest among potential employers. 
With the assistance of  the Global Fund, the Anti-drug Centre under the Patriarchy of  Georgia has been 
working on psychosocial rehabilitation of  drug users and their family members since 2007; in the frame 
of  the Global Found Program, 152 beneficiaries received individual and/or group psychotherapy in 2014; 
91 individuals referred to the Centre through the Church-Rehabilitation focal points. In total, 941 drug 
users or persons in remission received consultations on the hotline for users and their support network; 
172 users were trained as peer-educators. A priest specifically trained by the Centre led 50 group sessions 
with beneficiaries. In the framework of  the Global Fund project, the Centre conducts training for cler-
gymen of  Church-Rehabilitation focal points. Anti-drug Centre under the Patriarchy of  Georgia notes that 
Orthodox as well as non-Orthodox persons are among the beneficiaries of  the Centre. The majority of 
service users are men (Bekauri 2015).
Psychosocial Rehabilitation Centre Kamara is a local non-governmental organization, which has been 
functioning since 2010, providing assistance to people in recovery from drug addiction and their micro-so-
cial surrounding. Kamara offers the following services to substance-dependent individuals after detoxifica-
tion: psycho-diagnosis, cognitive-behavioral therapy, yoga, group therapy, art-therapy, mytho-drama and 
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music-therapy. Kamara’s activities are partially funded by the Global Fund and the Open Society Georgia Foun-
dation (Chokheli 2015). Most of  their programs are funded by private donations and contributions. Kamara 
creates informal and “family-like” environments for beneficiaries of  the Centre which facilitates retaining 
beneficiaries in the program for an average of  6-months. Kamara serves approximately 60 patients annual-
ly; however in 2014, 85 individuals benefited from these services. Of  the 85, only 2 were women. 
Kamara Rehabilitation Centre uses art-therapy which enables participants to create art in a therapeutic con-
text. This Program increases participants’ self-esteem and facilitates their social reintegration. There are 
public exhibitions where their artwork is sold. These exhibitions are aimed at reducing stigma and negative 
attitudes towards people who use drugs (Panjikidze 2015).
The unit for psycho-social rehabilitation and voluntary counseling and testing within the Centre for Mental 
Health and Prevention of  Addiction, supports psychosocial rehabilitation of  people who use drugs and is 
underwritten by the Global Fund. Patients enrolled in substitution therapy and people who have under-
gone in-patient and outpatient detoxification, receive rehabilitation through this unit. Beneficiaries are 
offered services including psycho-diagnosis, individual, group and family psychotherapy, cognitive–be-
havioral therapy, psychological counseling, art-therapy, ergo-therapy, conflict management, and self-help 
groups. Spiritual support is also organized by the Centre, as required and beneficiaries may meet Church 
representatives, who help them solve a variety of  problems and begin the canonical life. The Centre has 
a well-equipped gym where physical and healthcare procedures are offered to beneficiaries. In addition to 
fostering physical health, the Centre helps patients overcome such mental health problems as anxiety, de-
pression, and anger. The Centre supports vocational development through acquisition of  computer skills 
training. In 2014, the Centre served 52 individuals. A total of  21 people completed the full 3-6 month 
rehabilitation Program in 2014 (Todadze and Mosia, 2015).
The European Union funded project Establishing Social Bureaus for Former Inmates, Prisoners and 
Probationers in Georgia (Kasrelishvili, 2015) was implemented by the Centre for Information and Counseling on 
Reproductive Health Tanadgoma in partnership with international non-governmental organizations – Mainline 
Foundation and AIDS Foundation East-West. This project provides education and consultation to socially 
vulnerable populations on HIV, Hepatitis B and C, psychological and medical issues, overdose prevention, 
and psychological rehabilitation based on the 12 steps Program model. Communication skills develop-
ment training sessions are offered to Program beneficiaries who are seeking employment. In 2014 in Ba-
tumi, Kutaisi, and Zugdidi 631 individuals used social bureau services; 293 of  whom were former inmates, 
249 probationers, and 82 inmates. In 2014, the Project resolved problems for several beneficiaries such 
as the case of  a formerly incarcerated individual in Kutaisi who became homeless when he was rejected 
by his family and abandoned. Through assistance from the social bureau, he was designated as a socially 
vulnerable single person and temporarily placed in a shelter. In Zugdidi, former inmates were employed as 
waiters at a hotel and in the hazelnuts factory based on the recommendation of  the social bureau. How-
ever, these few cases are insignificant considering the scale of  the overall problem in the country. 
Currently there are no psychosocial rehabilitation services targeting female drug users; nor are there any 
plans to do so. Women with addictions suffer from double social stigma stemming from their status as 
women and their drug use.  In addition to problematic drug use, many of  these women are victims of 
domestic or gender-based violence. 
Given the scale of  the problem in Georgia, availability of  psychosocial rehabilitation services for drug us-
ers and those in recovery, including geographical accessibility to such services, is insufficient. In addition, 
long-term rehabilitation and social reintegration-oriented services remain fully dependent on funding of 
international donor organizations; which creates risk for the sustainability of  such services.
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9.1.  INTRODUCTION
Statistics on drug-related crimes presented here were obtained through publically available data and written 
requests for data from these public agencies - the Ministry of  Internal Affairs, the Chief  Prosecutor’s 
Office, and the Supreme Court of  Georgia.  
Primary drug offences are defined as a violation of  drug related articles under the Criminal and 
Administrative Codes of  Georgia. Secondary drug offences are defined as: the acts committed under the 
influence of  drugs; offenses committed to obtain money to buy drugs; or offences committed by drug 
market participants (e.g. selling of  drugs or violent crimes linked to the drug market). Secondary drug 
offences are not recorded in Georgia, therefore this report presents data on primary drug offences only.
9.2.  DRUG RELATED CRIME
9.2.1. Criminal Punishment for Drug Offences 
According to data supplied by the Supreme Court of  Georgia, in 2014, first instance courts heard 6,452 
cases against 6,666 persons accused of  committing crimes under Chapter 33 of  the Criminal Code of 
Georgia (CCG). The majority of  cases reviewed (> 95%) concerned drug related crimes under Articles 
260 and 273, accounting for 33.4% and 62% of  all cases heard respectively. Article 260 violations result 
in imprisonment penalties ranging from 6 months to lifetime for following acts: illegal preparation, 
manufacturing, purchase, storage, transportation, transfer or sale of  drugs, their analogues or precursors 
or new psychoactive substances. Article 273 violations result in sanctions (fine or imprisonment for a term 
of  up to 1 year) for the following actions: illegal preparation, purchase, storage or illegal use of  a drug, 
without doctor prescription, in small amounts for personal use committed two or more times during a 
12-month period. Two-thirds of  convicts under the Article 260 and one-fourth under Article 273 were 
sentenced to prison. Fines were issued as a primary and additional penalty to 45% of  individuals convicted 
under both Articles, and plea bargains were reached in 71% of  the cases (See Table 12).
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Table 12:  Number of  cases and individuals reviewed by the First Instance Court in relation to 
drug related offences in 2014 (Supreme Court of  Georgia 2015)
Criminal 
Code of 
Georgia
Heict 
Among 
those applied 
punishment 
Imprisonment Provisional Sentence 
Fine
(as primary 
sentence) 
Fine 
(as secondary 
sentence )
Community 
Works 
Heard with plea 
bargain
cases persons persons persons persons persons persons cases
260 2,156 2,354 1,515 802 37 1,215 144 1,858
261 57 59 9 12 38 16 53
262 130 132 78 10 44 36  92
263 2 2 2 2
264 1 1 1   1
265 113 114 53 60 1 63 98
271 1 1  1  1
273 3,993 4,003 972 2,082 805 741 2,618
Total 6,452 6,666 2,627 2,968 927 2,072 144 4,723
The number sentenced under Article 260 did not change significantly in comparison to the previous 
year (2013), however the number of  persons sentenced under the Article 273 increased noticeably. 
Imprisonment was used more frequently as a sanction in 2014 than 2013; 64% of  cases in 2014 compared 
to 45% in 2013 for Article 260 and 24% of   2014 cases compared to 12% of  2013 cases for Article 273 
(See Figure 16).
Figure 16:  Number of  individuals sentenced under Article 260 and 273 
of  CCG by years, 2007-2014 (Supreme Court of  Georgia, 2015)
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9.2.2. Administrative Offences
According to the information from the Ministry of  Internal Affairs of  Georgia, in 2014 50,865 persons 
were subjected to drug tests. Test results showed that 14,005 persons tested positive for the presence of 
drugs in their system; most commonly detected drugs were marijuana (61.7%), opium (22%), methadone 
(12%) and buprenorphine (9.3%). The same individual is generally tested for the presence of  several 
drugs. Therefore, data presented in Table 14 shows a sum of  positive test results for various substances 
exceeding the number of  persons who had positive drug panel screening results. Of  all those tested in 
2014, only 1% of  people tested were women (see Table 13).
Table 13:   Number of  persons tested for drugs in 2014 at the main forensic-criminology 
division of  the MIA (Ministry of  Internal Affairs of  Georgia 2015)
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January 6,482 2,139 4326 976 125 956 199 174 8 15 15 43
February 5,761 1,802 3,959 961 128 592 201 131 7 14 10 32
March 4,526 901 3,625 182 154 338 176 142 5 25 8 31
April 3,060 518 2,542 127 92 187 135 48 0 12 6 11
May 2,950 495 2,468 80 106 175 151 30 6 15 4 13
June 2,971 583 2,392 122 73 262 133 14 5 8 4 29
July 3,498 767 2,722 115 107 500 107 9 0 16 0 7
August 3,957 1,099 2,858 109 121 825 113 8 5 8 8 8
September 4,918 1,504 3,414 98 132 1,239 123 19 3 5 3 2
October 4,388 1,619 2,777 105 96 1,407 118 12 3 9 1 2
November 4,061 1,365 2,696 100 77 1,169 96 23 2 0 0   ---
December 4,293 1,213 3,081 92 93 996 111 21 4 5 3 1
Total 50,865 14,005 36,860 3,067 1,304 8,646 1,663 631 48 132 62 179
Table 14:  Number of  individuals by sex tested for drugs in 2014 by the main 
forensics-criminology division of  the MIA (Ministry of  Internal Affairs of  Georgia 2015)
Sex Women Men Total
Tested 485 50,380 50,865
Positive 112 13,893 14,005
Proportion of  positive cases (%) 23 27.6
Marijuana and opioids were the most frequently consumed drugs among those who tested positive in 2013 
and 2014. There was a significant increase in detection of  marijuana consumption in 2014 from 2013, and 
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a significant decrease in opioid detection (See Figure 17). There has been a stable and substantial increase 
in detection of  marijuana consumption since 2007. 
Figure 17:  Percentage of  types of  drugs people tested positive for during street 
drug testing in 2007, 2013 and 2014 – five most frequently detected drugs 
(Ministry of  Internal Affairs of  Georgia, 2008, 2014, 2015)
 
Compared to 2013, the number of  persons tested for drugs in 2014 had decreased by approximately 
10,000 (See Figure 18). The proportion of  positive results decreased as well; in 2014 positive results 
accounted for 27.5% of  cases compared to 37.7% of  those tested in 2013.
Figure 18 : Number of  tested persons and positive results, 2006-2014
(Ministry of  Internal Affairs of  Georgia, 2007-2015)
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According to data from the Supreme Court of  Georgia, in 2014, 9,161 rulings were made based on Article 45 of 
the Administrative Code of  Georgia (consumption of  controlled substances without doctor’s prescription), of 
which 95% (n=8,694) resulted in monetary penalties. Unfortunately, since 2011 government offices have 
been unwilling to provide data on amount of  fines collected for these violations. They have responded to 
written requests for this information by saying they cannot run statistics on the amounts paid based on 
this Article. However, prior to 2011 such information was available at the Supreme Court. 
Table 15: Rulings of  the First Instance Court based on the Article 45 of  the Administrative 
Code of  Georgia related to drug testing in 2014 (Supreme Court of  Georgia 2015)
Judicial decisions Number of  individuals
Administrative imprisonment 115
Monetary penalty 8,694
Released from administrative responsibility 261
Case transferred to Prosecutor’s Office for 
further investigation 91
 Total 9,161
9.3. PREVENTION OF DRUG-RELATED CRIME
Georgia does not have a separate drug-related crime prevention strategy, and it is presumed that measures 
aimed at general crime prevention include components of  drug use prevention as well. For example, the 
LEPL Crime Prevention Centre under the Ministry of  Justice works on those matters, and facilitates rehabilitation 
and social reintegration of  inmates following their release from prison For details please refer to chapter 
3 sub section 3.5.
9.4. DRUG USE IN CORRECTIONAL FACILITIES
By December 2014, the combined population of  15 correctional facilities across Georgia totaled 10,372 
accused and convicted individuals, of  which 2.7% (n=281) were women (Ministry of  Corrections of 
Georgia 2015). The number of  prisoners who have a history of  psychoactive substance use is not available. 
Ministry representatives admit that the use of  psychoactive substances within its’ facilities is a problem, 
however no precise data are available. As in previous years it is considered that Georgian prisons are drug 
free (i.e. drugs are not channeled into prisons), and, therefore not used. This subject was reviewed in detail 
in the 2013 Report. 
9.5. RESPONSES FOR DRUG USERS IN PRISONS 
According to 2014 Report of  the Ministry of  Corrections of  Georgia: “Penitentiary health reform was successfully 
completed in 2014 (so-called “18-months reform”), which were designed to complete transformation 
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of  the system in 2013-2014 (Ministry of  Corrections of  Georgia, 2014 Report 2014). These reforms 
envisaged system changes, which included improvement of  prison medical infrastructure and capacity 
building of  medical staff. More detailed information on changes introduced in the Penitentiary System in 
recent years was presented in the 2013 Report.
9.5.1. Treatment of  Drug Addiction in Correctional Facilities
According to 2014 Report of  the Ministry of  Corrections, coverage of  addiction services in the penitentiary system 
increased, namely new addiction treatment units opened, an awareness campaign against psychotropic 
medication dependence began, agreements with civil sector addiction clinics were signed and treatment/
rehabilitation of  inmates was initiated including methadone detoxification expansion and  introduction of 
long-term substitution therapy (Ministry of  Corrections of  Georgia 2015b).
Specialized addiction treatment is available in three correctional facilities. Methadone detoxification 
Programs are available in pre-trial detention facilities in Tbilisi and Kutaisi. In addition, the central 
penitentiary hospital offers abstinence oriented treatment to inmates requiring such treatment. In 2014 
474 accused and convicted inmates completed methadone assisted detoxification treatment, including 
four women. In-patient detoxification course were also delivered to four inmates. 
9.5.2. Harm Reduction Activities 
Harm reduction Programs have not been introduced to prisons. Similar to previous years it is presumed 
that illegal drugs do not enter prisons and therefore no drugs are used within the facilities. The only harm 
reduction component, which was implemented under the aegis of  the HIV/AIDS prevention measures 
in correctional facilities, has been the voluntary counseling and testing (VCT). VCT offices function in all 
but two correctional facilities. This service is funded by the grant of  the Global Fund. 
9.5.3. Access to healthcare services and their delivery to drug users in correctional 
facilities 
According to data from the Ministry of  Corrections, in 2014 8,000 individuals in correctional facilities 
were tested for HIV and Hepatitis C virus. There were 34 HIV-positive results and 3,800 HCV-positive 
individuals (Ministry of  Corrections of  Georgia 2015a). In the frame of  the State Program for Elimination 
of  Hepatitis C, inmates are provided with universal access to specific services, which means that those 
requiring HCV treatment have an opportunity of  receiving it. Antiretroviral treatment for HIV/AIDS 
was delivered to 75 patients (Ministry of  Corrections of  Georgia, 2014 Report 2014).
9.6. REINTEGRATION OF DRUG USERS AFTER RELEASE FROM 
PRISONS
Currently prisons do not operate any specific programs aimed at reintegration of  drug users after release 
from prisons. Psychosocial reintegration programs are funded through the European Union and non-
governmental organizations (NGO’s). 
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As for post-prison psychosocial rehabilitation programs, the European Union funded project Establishing 
Social Bureaus for Former Inmates, Prisoners and Probationers in Georgia was implemented and has been in oper-
ation since 2012 by the Centre for Information and Counseling on Reproductive Health Tanadgoma in partnership 
with international NGO’s – Mainline Foundation and AIDS Foundation East-West. The Project offers former 
prisoners counseling on HIV/AIDS, Hepatitis B and C, overdose prevention and psychological rehabili-
tation based on the 12 steps Program model, in addition to communication skills training for those seeking 
employment. For more detailed information see Social Integration section of  chapter 8 in this report. 
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10.1.  INTRODUCTION
Due to lack the of  monitoring of  drug situations no comprehensive or consistent information on the 
circulation of  illegal drugs and illicit drug market parameters have been collected to date. The primary 
sources of  information for data on drug markets presented in this section are derived from addiction 
service providers, the Ministry of  Internal Affairs (MIA) website, and letters from the MIA. The MIA 
letters were prepared and sent to the Annual Report team in response to our written requests for specific 
information. In addition data on drug use trends was provided by addiction service providers regarding 
the prevalence of  drug use among their clientele.  
10.2.  DRUGS TRAFFICKING AND SUPPLY
Georgia does not have an organized mass manufacturing of  drugs to supply domestic and/or external 
markets. The situation is quite the opposite, whereby preparation of  homemade “small batch” synthetic 
injecting drugs (opioids and stimulants) is common practice among drug users in Georgia. Small networks 
of  drug users (usually 3-5 people) prepare and use drugs at home. This type of  drug production is for 
individual use only and there is no information to indicate distribution and/or sale of  such homemade 
drugs. 
It is currently not possible to assess availability of  particular drugs in any reliable and valid way; the 
only available information comes from government reports on the amounts of  drugs seized from illegal 
circulation or the frequency of  various drugs used in specific period of  time. Neither drug seizures nor 
drug tests performed by the law-enforcement authorities are used as an indicator of  availability and 
accessibility of  specific drugs (See Figure 17 for the most common positive drug tests results which 
include marijuana, opium, buprenorphine, methadone, and meth/amphetamines). For example, the 
largest seized amount of  heroin in 2014 (592 kg – see Table 18) does not mean that heroin would have 
become unavailable in the Georgian drug market. Similarly, data from Georgian Harm Reduction Network and 
epidemiological surveillance surveys shows that in 2014 consumption of  heroin and buprenorphine had 
increased (See Figure 17); however this does not necessarily indicate increased availability of  those drugs. 
It is possible that in addition to availability users’ choice of  specific drug is affected by other factors.
10.2.1. New Psychoactive Substances
Information related to the availability of  new psychoactive substances is given in the 2014 Drug Situation 
Report of  the Ministry of  Internal Affairs (within MIA competence) and the First Annual Report on 
Situation on New Psychoactive Substances (Ministry of  Internal Affairs of  Georgia, 2014; Ministry of  
Internal Affairs of  Georgia, 2015a). According to these Reports, since 1 May 2014 (date of  enactment of  
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the Law on New Psychoactive substances) the detection rate of  use (based on the results of  street drug testing) 
of  new psychoactive substances reduced by 90% in a single 12-month period (from May 2013 – June 
2014 n= 687 cases; from May 2014-June 2015 n=53 cases). Detection of  import of  new psychoactive 
substances significantly reduced in the same period of  time – 53 cases vs. 5. Authors of  the MIA Re-
ports have interpreted this data as a reduction of  use of  new psychoactive substances by 90%. Common 
standards of  epidemiology and drug situation monitoring suggest that indicators of  reduced detection 
of  specific substance by drug tests or reduced interdiction and detection of  substances on the border are 
not sufficient for arriving at the conclusions drawn by the MIA. Moreover – supply of  new psychoactive 
substances (NSP’s) varies and the NSP’s on the market are changing rapidly and thus cannot be detected 
in drug screening tests.
10.3. SEIZURES
In 2014 the largest amount of  drugs in the history of  Georgia were seized from illegal circulation. The 
primary drugs seized were heroin and cannabis. This may be attributed to an increased influx of  these 
given substances as well as the effective work of  police forces or revision of  policing work priorities. Table 
16 shows the quantities of  drugs seized in 2006-2014.
Table 16 : Amount of  drugs (pure substances) seized from illegal circulation in 2006-2014 
(Ministry of  Internal Affairs, 2007-2015)
2006 2007 2008 2009 2010 2011 2012 2013 2014
Heroin (kg) 8.59 16.15 12.11 5.05 1.71 0.47 0.29 117.62 591.89
Opium (kg) 0.22 0.14 0.05 0.12 0.09 0.09 0.01 0.05 0.21
Marijuana (kg) 26.24 23.64 28.29 43.70 27.06 48.47 30.08 71.60 57.39
Tramadol (kg) 0.07 0.1 0.73 0.13 0.21 0.02 0.01 0.14 0.730
Cannabis plants (kg) 123.03 64.85 41.56 100.25 26.88 88.91 21.07 217.77 5,420.8
Methadone (kg) 0.02 0.21 0.32 0.29 0.03 0.003 0.04 0.009 0.14
Subutex (tablets) 10,852 16,232 13,757 7,022 2,815 3,031 777 1,678 -----
Amphetamine (g) 0.0063 0.68 0.87 0.29 0.19 0.26 57.52
Methamphetamine (kg) 0.002 0.0004 0.002 0.003 0.008 0.002 0.001 0.003 0.06
Morphine (kg) 0.003 0.004 0.03 0.006 0.007 0.005 0.004 0.002 11.76
Codeine (kg) 0.03 0.01 0.03 2.29
Fentanyl (kg) 0.0004 0.0008
Desomorphine (kg) 0.001 0.01 0.0006
Cocaine (kg) 0.0005 0.001 0.13 0.008 0.002 0.50
Ephedrine (g) 1.19 1.02 3.68 7.59 1.86 1.01 0.79 0.00015
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Ecstasy (MDMA) (g) 0.000002 0.01 0.077 0.071
Pseudoephedrine (g) 0.07
Tramadol (kg) 0.07 0.1 0.73 0.13 0.21 0.02 0.01 0.14 0.73
LSD (g) 0.0014 0.0019 0.0015
Pregabalin (kg) 0.59 15,4
Poppy seeds (kg) 2.02 0.28 13.93 8.22
Buprenorphine (kg) 0.25
* - Data in the Table may differ 
from data in previous annual 
reports. This report used the 
most recent data supplied 
by the MIA in the letter 
N2747853 dated December 
12, 2015. Although all previous 
Annual Reports also used MIA 
information, in some cases the 
most recent data differ.
10.4. PRICE/PURITY
Reliable and comprehensive information on price and purity of  drugs consumed in  Georgia is unavailable.
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ACRONYMS
HIV/AIDS –  human immune deficiency virus/acquired immune deficiency syndrome
ARV –   antiretroviral treatment 
VTC -   Voluntary Testing /Consultation
MIA –   Ministry of  Internal Affairs
BBSS –  Bio Behavioral Surveillance Survey 
EMCDDA –  European Monitoring Centre for Drugs and Drug Addiction – 
ESPAD –  European School Project on Alcohol and Other Drugs – 
EUDAP –  European Drug Prevention Program 
GARP –  Global AIDS Report 
GHPP –  Georgian HIV Prevention Program 
GHRN –  Georgian Harm Reduction Network 
HRDU –  High Risk Drug Use
MSY –   Ministry of  Sports and Youth Affairs
NCDC –  National Centre for Disease Control
PDI –   Peer Driven Intervention
RPR –   Rapid Plasma Reagin 
UNAIDS –  United Nations AIDS Fund 
UNICEF –  United Nations Children’s Fund 
UNODC –  United Nations Office on Drugs and Crime
UNGASS –  United Nations General Assembly Special Session
USAID –  United States Agency for International Development
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